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Context: The intramuscular (IM) injection is an important route of drug administration. 
Some researchers have suggested that the erratic rate of drug absorption from oil-based 
IM injections is due to variability in the spread of the formulations from the injection 
site. Recently, the application of ultrasound (US) has been investigated as a possible 
strategy to enhance the spread of IM injected formulations and thereby reduce 
variability in drug absorption. 
Objective: The aim of the research reported in this thesis was to investigate the effects 
of US on the spread of IM injected formulations. 
Methods: For in vitro experiments, transparent agarose gel was used as the matrix. 
Both Nile blue(aqueous) solution (0.001% w/w) and Nile red(oily) solutions 
(0.01% w/w) were prepared and injected into gels. The area of spread of injected 
formulations was photographically recorded and measured immediately after injection. 
US (1.1 MHz, 3 W/cm2) was then applied to the injection site using a 6 min on-off 
working cycle for 60 min after which the area of spread was measured again. Areas of 
spread determined as mean ± standard deviation before and after US treatment were 
compared. For in vivo experiments, three Wether lambs (6 to 8 months old, 32 kgs 
approx.) were subjected to IM injections post-mortem.  Three different types of 
formulation (Lipiodol: ethyl esters of iodized fatty acid of poppy seed oil, 48% w/v 
iodine; oily suspension: barium sulfate in Miglyol 812, 30% w/w;  and a self-
emulsifying drug delivery system (SEDDS): mixture of Lipiodol, Maisine and Miglyol, 
40:20:40%, w/w)) were prepared and two different injection volumes (1.5 and 4.5 mL) 
injected into muscle. US (1.1 MHz, 3 W/cm2, 100% working cycle) was applied for 0, 
5 and 10 min at the injection site and the spread of formulations visualized by CT scan 
and measured before and after US application. The collected data was analysed using 
two-way ANOVA and Tukey test for post -hoc statistical analysis. Muscle tissue 
containing injected formulations was frozen in liquid nitrogen and subsequently 
examined by dissection.  
Results: In the in vitro study, 60 minutes after injection, the spread of both aqueous and 
oily solutions remained unchanged after application of US. In the post-mortem study, 
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the initial spread showed no significant difference between either type of formulation or 
injection volume. After application of US for 5 min, a significant increase in spread 
was observed for the oily suspension and SEDDS using an injection volume of 4.5 mL; 
after exposure to US for 10 min, significant increases in spread were found for the oily 
suspension and SEDDS at both 1.5 and 4.5 mL injection volumes. The subsequent 
dissection revealed a large amount of injected formulation outside the injected muscle 
bundle resulting from spread along the fat layer and into the inter-muscle space.  
Conclusion: There is no effect of US on the spread of formulations injected into 
agarose gel. In the post-mortem study, the CT scan proved to be suitable to visualize 
the spread of IM injected formulations. The initial spread of the IM injected oil 
formulations showed high variation.  US-induced spread was observed for the oil 
suspension and SEDDS. The mechanism behind the enhanced spread needs further 
investigation but could be related to the ability of applied US to reduce the viscosity of 
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The intramuscular (IM) injection is an important means of drug administration for 
vaccines, antibiotics and hormones. The sites of IM injection include the deltoid, lateral 
gluteal, vastus lateralis and posterior gluteal muscles (Morrissey 2011). Unfortunately 
the rate of IM drug absorption is somewhat erratic (Zuidema et al. 1994) leading to 
highly variable arterial drug concentrations (Zuidema et al. 1994). A satisfactory 
explanation for this variable rate of IM absorption has yet to be found although research 
suggests it arises due to variability in the spread of IM injected formulations (Gehling 
et al. 2018).  
Absorption, distribution, metabolism, and excretion (ADME) have been the main focus 
of research into the pharmacokinetics of drugs delivered by IM injection. In most 
situations, absorption is described as the process by which a drug moves from the 
injection site into surrounding blood capillaries. However, some literature indicates that 
spread of the injectate must take place before absorption begins and has a significant 
effect on the subsequent absorption (Darville et al. 2016). In clinical practice, the 
process of injection pushes the injectate into the targeted muscle bundle to create and 
fill a cavity often described as the injection depot. Spread then follows the pressure 
gradient and depends on the injection site and injection volume. Due to the elasticity of 
muscle, sometimes the injectate can be lost from the muscle by being squeezed back 
along the needle track and/or spreading outside the muscle bundle i.e. there is intra- and 
extra-muscular spread. Whatever the case, spread is usually finished quickly and is 
followed by absorption of drug into the surrounding capillaries.  
Descriptions of spread based on observational studies have varied. Brown et al. 1944 
stated that IM injected oils tend to accumulate along fascial sheaths and, to some 
extent, between muscle bundles. Later, Berton 1968 compared the spreading of oil and 
water-based formulations and found the latter spread immediately whereas the former 
tended to form a sphere-shaped deposit around the needlepoint. Svendesen 1979 
showed that IM injections of low viscosity oil spread between muscle fibers and around 
fascicles and Howard, 1983 showed that arachis oil given by IM injection to rabbits 
spreads more slowly, probably due to its higher viscosity, than ethyl oleate. More 
recently, it was again reported that IM injected formulations can squeeze back along the 
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track of the needle eventually leading to leakage into extra-muscular tissue (Bjerregaard 
et al. 2001, Gehling et al. 2018). 
The main problem of administration of drugs by IM injecction is the erratic nature of 
the spread of their formulations. A few attempts have been made to overcome this 
erratic spread particularly as it relates to formulations in an oily medium. One 
researcher suggested that using deep, firm massage of the tissue around the injection 
site would facilitate more consistent absorption (Zelman 1961). Recently, the 
application of ultrasound (US) has been suggested as a potentially useful strategy to 
improve the uniformity of spread of various types of formulation in tissue (Frenkel et 
al. 2000a).  
Medical research has shown that US usually gives rise to both thermal and non-thermal 
effects on human tissue (Baker et al. 2001, O'Brien Jr 2007). To study the thermal 
effect, Draper 1995 determined the temperature 30 mm under the skin during 
application of 1 MHz, 1.5 W/cm2 US to the skin of the human upper arm. They found 
that after 10 min of continuous US exposure the temperature increased by 5°C (Draper 
et al. 1995). Robinson et al, 1995 observed an increased blood flow in the skeletal 
muscle of healthy human volunteers after application of 1.5 W/cm2 US for 5 min. Also 
Frenkel et al, 2001 showed that US can increase the mass transport of silver particles in 
the tissue of fish. The non-thermal effects of US are related to its mechanical effects, in 
particular the process of cavitation. However, it is well known that cavitation is very 
difficult to induce in vivo without the use of a gas bubble agent (Miller et al. 2002). 
Although US has the potential to enhance spread, there is no direct evidence that it 
actually enhances the spread of formulations in muscle tissue.  
In this thesis, the spreads of various types of formulations administered by IM injection 
were studied in vitro in gels and muscle pieces and in vivo in animals immediately 
post-mortem. The influence of exposure to 1.1 MHz US for various lengths of time on 
the spread of the formulations was also studied. In this Chapter, aspects of muscle 
structure relevant to the spread of IM injections (Section 1.2), the mechanisms 
suggested for their spreading (Section 1.3), US and its effects (Section 1.4), the 
challenges of visualizing the spread (Section 1.5) and formulation considerations 
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(Section 1.6) are described. Research questions and the hypotheses of the thesis are 
then given in Section 1.7. 
1.2 ANATOMY OF MUSCLE 
As shown in Figure 1-1, skeletal muscle is surrounded by a connective tissue layer 
called the fascia. Epimysium is specialized fascia and ensheaths the entire muscle. The 
muscle contains multiple bundles called fascicles each of which is surrounded by 
another connective tissue layer called the perimysium. Within each fascicle, individual 
muscle cells take the form of fibres which are surrounded by the endomysium, the third 
layer of connective tissue (Fratzl 2008). All above connective tissue layers contain 
capillaries, nerves and lymph (Robert Schleip 2012). The thickness of the perimysium 
is reported to be 30-40 µm in human muscle (Fang et al. 1999) whereas the thickness of 
the endomysium is in the range 0.2-1.0 µm (Schmalbruch et al. 1974).  
 
Figure 1-1Schematic diagram of a cross section of muscle tissue. 
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Although the microanatomy of muscle tissue is not the main focus of this thesis, a few 
important points are worth mentioning because they relate to the spread of IM injected 
formulations. First, the water content and its distribution in muscle have an influence on 
the spread of an IM injected formulation because water can act as a solvent (Zuidema et 
al. 1988). Lean muscle contains approximately 75% water (Rajanayagam et al. 1991), 
most of which (85%) is located within the muscle fibre (Pearce et al. 2011) with only 
some 15% being found between the muscle fibres and the inter-fascicular space (Offer 
et al. 1983). Secondly, the thickness and length of the intermuscular fat layer can affect 
spread since they vary depending on the percentage of body fat and the injection site.  
1.3 MECHANISM OF SPREAD  
1.3.1 General mechanics of IM Injection  
From a mechanical point of view, the spread of a formulation administered by IM 
injection is a simple process (Figure 1.2). In using a syringe, injectate receives both 
pushing force and shear force. The shear force comes from the wall of the syringe and 
needle. The shear force increases while the injectate is being pushed through the needle 
due to the diameter of needle being much smaller than syringe. After the needle has 
pierced through the skin and subcutaneous tissue, it reaches the target muscle. The 
injectate is pushed out from the needle, then forms an injection depot. The injection 
depot experiences a force of resistance resulting from elasticity of the muscle. After the 
injection is finished and the pushing force from the syringe is no longer present, the 
injectate is pushed by the elasticity of muscle into tissue with less resistance, such as 
the needle hole and connective tissue layers. In the muscle the depot, once formed, is 




Figure 1-2 Diagram shows basic mechanics of IM injection. 
Depending on the type of formulation injected, there can then be various types of 
interface between the depot and the surrounding matrix. If the formulation is aqueous, a 
water-water interface is formed whereas if it is oily, an oil-water interface is formed. 
The following behaviour of the injection depot can be explained in two theories: mass 
transfer (Section 1.3.2), free surface energy and surface tension (Section 1.3.3).  
1.3.2 Mass transfer 
In this thesis, mass transfer is the movement of molecules of a fluid in muscle. In 
general, mass transfer is a kinetic process, occurring in systems that are not at 
equilibrium. In order to understand the thermodynamic basis of mass transfer, consider 




Figure 1-3 Isolated system consisting of two sections separated by an imaginary 
permeable membrane. At equilibrium, the temperature (T), pressure (P), and chemical 
potentials of each of the species in the system are equal in the two sections (Gordon L. 
Amidon 2000) 
The isolated system is bounded by an impermeable wall which stops the transfer of 
matter, heat, or mechanical energy. The system is separated into two sections of equal 
volume, as labelled I and II in Figure 1-3. The sections are separated by an imaginary 
membrane, which is permissive to the transfer of mass, heat, and mechanical energy. At 
equilibrium, the temperatures, T, pressures, P, and chemical potentials, μ, of the species 
are equal in two sections.  
If this isolated system is unperturbed, it will remain at this thermodynamic equilibrium 
indefinitely. Suppose that the pressure in section I is increased, which means P1 > P2, 
while the temperatures and all chemical potentials remain equal in the two sections. 
Thermodynamics asserts that as a result of this perturbation the system will change in 
an attempt to establish a new equilibrium condition (Gordon L. Amidon 2000). One of 
the simplest changes that can be imagined is the re-equilibration of the two pressures P1 
and P2, with no change in the values of the temperatures or chemical potentials. If the 
imaginary membrane is fully permeable to the fluids in the system, the re-equilibration 
of the pressures will occur through the flow of fluid from section I to section II, which 





















will continue until the values of P1 and P2 are again equal. This flow of fluid in 
response to a spatial gradient in pressure is called convection (Gordon L. Amidon 
2000).  
Suppose that the chemical potential of one the species, A, is now increased in section I 
so that μ1 > μ2. The system is perturbed from equilibrium and will change in order to 
establish a new equilibrium. One of the simplest changes is the re-equilibration of the 
chemical potentials of species A, without change in the other variables. If the imaginary 
membrane is permeable to species A, the re-equilibration will occur through the 
movement of A from section I to section II, which will continue until the chemical 
potentials are equal again. This movement of mass in response to a spatial gradient in 
chemical potential, and as the result of the random thermal motion of molecules, is 
called diffusion (Gordon L. Amidon 2000).  
Thus an injection depot may spread caused by pressure from the elasticity of muscle. 
This is convectional movement. Absorption of drug, or solvents, from the depot is 
thought to occur by diffusion (Hirano et al. 1981c).  
1.3.3 Free surface energy and surface tension 
If the surface of a liquid increases, as occurs when a depot of oil breaks into droplets, 
the free energy of the liquid increases in proportion to the increase in the surface area 
(Martin 2006). Surface tension is a force that contracts the surface of a liquid and 
reduces the area of the interface. Thus when the interfacial tension between liquid of 
the depot and the surrounding material is decreased, it is easier to break the depot liquid 
into smaller droplets or for it to spread (Howard et al. 1983). Surface free energy (and 
surface tension) can be affected by factors such as the presence of surfactant and 
temperature as well as US. US does not only affect the free surface energy of injectate, 
but also applies mechanical and thermal effects on the tissue of injection site.  
1.4 US AND ITS EFFECTS 
1.4.1 US and acoustic/thermal properties of human tissues  
US is an acoustic wave with a frequency higher than 20 kHz (Lele et al. 1975) although 
most medical applications utilise a frequency range of 1 MHz -15 MHz. Therapeutic 
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US works around 1 MHz but most diagnostic applications are in the frequency range 
2.5 MHz -7.5 MHz (ter Haar 2007). US can propagate in various media including 
gases, liquids and solids.  
The ultrasonic wave is classified into either longitudinal or shear waves depending on 
the type of motion induced in the medium by the propagating sound wave (O'Brien Jr 
2007). Longitudinal waves occur when particles of the medium move back and forth in 
the direction of the wave thereby creating areas of high and low pressure in the 
medium. Shear waves occur when the particles move at right angles to the direction of 
the wave. Longitudinal waves can travel through all kinds of material whether gas, 
liquid or solid, but shear waves can only occur in solid materials. Thus shear waves 
have only limited ability to propagate through soft tissue because of its high percentage 
of liquid but can exist in harder biological materials such as bones (Baker et al. 2001).  
The propagation of US is therefore highly influenced by the physical properties of the 
medium. The acoustic and thermal properties of water and human tissues (i.e. how they 
respond to sound waves and heat) are listed in Table 1-1 (López-Haro et al. 2015, 
Nowak et al. 2015).  
Table 1-1 Acoustic and thermal properties of water and human tissues at 37°C. 
 Acoustic properties Thermal properties 
 Speed (m/s) Attenuation 





Water 1527 0.22 4178 0.6 
Skin 1540 230–470 3898 0.209 
Fat 1420 6–52 3221 0.402 




As regards the acoustic properties, attenuation is inversely proportional to the 
frequency of the applied US (Hayes et al. 2004). In previous studies, a frequency range 
of 1.5 MHz –10 MHz has been tested in human liver (Gammell et al. 1979, Hynynen et 
al. 2005) whereas a frequency of 0.69 MHz was tested in rabbits (Wells 1977). 
Generally a frequency of 1 MHz -3 MHz is used in both human and animal studies 
(Hayes et al. 2004, Miller et al. 2012). As for thermal properties, the skin has a higher 
heat capacity than either fat or muscle. It also has a lower thermal conductivity meaning 
that heat induced by US in skin has only limited ability to pass to the underlying tissue. 
The heat capacity of muscle is similar to that of skin, but fat has a lower heat capacity 
and higher thermal conductivity.  
In biological applications, the propagation of US is a process of transferring energy to 
tissues. The effects of US are divided into either thermal effects or non-thermal 
mechanical effects.  
1.4.2 Thermal effects of US 
When ultrasonic energy is propagated in tissues, around 80% of the energy is converted 
into heat (López-Haro et al. 2015, Nowak et al. 2015). The temperature of the tissue 
may then increase depending on whether the rate at which heat is produced exceeds that 
at which it is removed. Depending on the parameters of US, the thermal effects result in 
various effects from mild warm to lesion in muscle. Based on the literature, exposure of 
bovine skeletal muscle to 1.03 MHz, 2 W/cm2 US for 4 min caused a temperature 
increase from 37°C to 46.2°C at a depth of 20 mm (Cortela et al. 2016). In human 
muscle exposed to 3 MHz, 1.5 W/cm2 US for 3.4 min, the temperature increased from 
35.5°C to 40°C at a depth of 2.5 cm (Hayes et al. 2004). Another study in human 
medial triceps surae showed that application of 1 MHz, 2 W/cm2 US for 10 min 
increased the temperature by 4°C at 2.5 cm depth (n=24) (Draper et al. 1995). This US-
induced local hyperthermia can result in increased blood flow to the muscle (Wust et al. 
2007).  
1.4.3 Non-thermal effects of US 
Non-thermal effects of US include cavitation, acoustic radiation force, and acoustic 
streaming (Dayton et al. 1999, Frenkel 2008). In clinical applications, cavitation is 
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usually induced due to injection of US contrast agents or gas microbubbles. However, 
there is no experimental evidence to suggest that inertial cavitation occurs in 
mammalian parenchymal tissue i.e. endogenous cavitation appears to be rare in most 
tissues (O'Brien Jr 2007).  







       equation 1.1 
where W is the acoustic power, c is the propagation speed and α is the absorption 
coefficient, I is the temporal average intensity of the acoustic wave at the given location 
in W/cm2. If the radiation force is large enough, it is capable of causing local 
displacement of tissue (Torr 1984).  
Acoustic streaming results from attenuation of an acoustic wave by the medium 
(Frenkel et al. 2001). The velocity of acoustic streaming is proportional to the intensity 
of the US, the surface area to which it is applied and the attenuation coefficient of the 
medium; it is inversely proportional to the bulk viscosity and the speed of sound in the 
medium (Barnett 1998). The radiation force and acoustic streaming demonstrate the 
ability to move or redistribute agents from the luminal space towards the walls of the 
vessels at a velocity of 0.5 m/s (Dayton et al. 2002). Frenkel et al. carried out a series of 
studies showing that non-cavitation US (3MHz, 2.2W/cm2) can increase mass transport 
into skin and non-destructive widening of the intercellular spaces between epithelial 
cells at the fluid-tissue interface (Frenkel et al. 2000b). The authors explained that the 
above phenomena were caused by a steep gradient in shear force created by ultrasonic 
waves.  
The non-thermal effects of US produce extra pressure or shear force which possibly 
influence the convective spread of formulations administered by IM injection. To date, 
there is no mathematical model or theory that can describe how US affects the spread of 
IM injected formulations. Furthermore, the challenge of this research is not only to 
describe how US affects the spread of IM injections but also how to visualize and 
measure spread.  
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1.5 THE CHALLENGE TO VISUALIZE SPREAD 
Based on the literature, the spread of an IM injection is usually visualized by adding a 
fluorescent dye or contrast medium (the agent) to the formulation and using the 
appropriate detection system to capture images during the spread(Nguyen et al. 2011, 
Zhang et al. 2013, Dauffenbach et al. 2014, Seo et al. 2015). Each captured image 
consists of many pixels each representing a small area which is usually processed in a 
binary mode where the pixels are either black or white. The muscle then appears black 
and the injectate white due to the agent in it. However, if the concentration of agent is 
below a certain threshold, the pixel shows black and appears like muscle or fat. As the 
agent is released from the injection depot into the surrounding capillaries, its 
concentration in the depot drops while that in the surrounding capillaries rises. It is then 
possible for the concentrations of agent in both injection depot and capillaries to be 
higher than the threshold and for an erroneously large spread to be observed. With 
current image processing technology, it is difficult to completely avoid this erroneous 
measure of spread.  
1.6 FORMULATION CONSIDERATIONS 
Suspensions and solutions are commonly used as injectable pharmaceutical 
formulations that are convenient to use and active immediately. Emulsions have 
received attention in recent years as a vehicle for drug delivery by injection. An 
emulsion can be defined as a mixture of two (or more) immiscible phases with a third 
component, usually an emulsifier, added to stabilize the dispersed droplets (Davis et al. 
1987). By the nature of the dispersed and continuous phases, emulsions can be 
classified as either oil-in-water (o/w) or water-in-oil (w/o) systems. The self-
emulsifying drug delivery system (SEDDS) has been shown to improve the solubility 
and absorption of poorly water-soluble drugs (Neslihan Gursoy et al. 2004) and reduce 
pain on injection (Westrin et al. 1992). However, research into the spread of SEDDS 
given by IM injection is very limited. One study showed a w/o emulsion containing 
small ellipsoid droplets (radius 150 µm – 350 µm) spread beneath the epimysial, fascial 
sheaths and within the perimysial septa (Bjerregaard et al. 2001). The interaction 
between different types of formulation and US remains unclear.  
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1.7 RESEARCH QUESTIONS AND HYPOTHESIS 
Although the IM injection is widely used in both human and animal healthcare, there is 
an awareness that absorption of injected formulations is highly variable due to uneven 
and inconsistent spread. This has led to interest in the potential of US to improve the 
spread of IM formulations. However, it remains unclear which factors or 
physicochemical properties are critical for the spread of IM formulations leading to the 
need for greater understanding of the interaction between US and spread in artificial 
and real muscle.  
Considering this situation, the following research questions are of interest: 
• Does US influence the spread of formulations administered by IM injection?  
• Which factors are critical for the spread of injected formulations in artificial and 
real muscle?  
The following factors have the potential to influence spread and are of particular 
interest: 
Table 1-2 Factors potentially able to influence the spread of an intramuscular injection 
Factor 
Formulation Ultrasound Other 
Hydrophilic vehicle Duration of exposure Temperature 
Lipophilic vehicle Frequency  
Viscosity Intensity  
Surfactant   
Injection volume   





The hypothesis of this study is therefore:  
Formulation factors and physical and thermal effects of US can influence the spread of 
liquid formulations at the IM injection site.  
1.8 AIMS OF THE THESIS 
The aim of this thesis was to study formulation properties and the effects of US on the 
spread of formulations administered by IM injection to artificial and real muscle. 
Specifically, the objectives were:  
i) To carry out in vitro experiments to study the spread of an injected formulation in 
agarose gels with and without the application of US (Chapter Two);  
ii) To carry out post-mortem animal experiments in wether lambs using a balanced 
factorial design to study the effects of US on the spread of IM injected formulations, in 
particular investigating the influence of the duration of application of US, the type of 
formulation and the volume of the injection on the spread  (Chapter Three);  
iii) To compare and discuss the results of both in vitro and post-mortem studies in order 
to understand the influence of US on intramuscular spread and suggest future research 









CHAPTER TWO  
EFFECT OF ULTRASOUND ON THE SPREAD OF 





This Chapter describes studies of the effect of US on the spread of aqueous and oily 
solutions of dyes in gel phantoms. Gel phantoms or tissue-mimicking phantoms are 
transparent gels suitable for use in US studies since they possess similar acoustic and 
thermal properties to those of muscle (Takegami et al. 2004). In the literature, two types 
of gel phantoms prepared using agarose gel and polyacrylamide gel and both containing 
egg white have been widely used (McCabe 1972, Zhi-Jian et al. 2002, Divkovic et al. 
2007). In this study agarose gels were used because: 
1) They have similar thermal and acoustic properties to muscles. As noted in section 
1.4.1, the attenuation of muscle is from 48 dB/m to 100 dB/m at 1 MHz. The 
attenuation of 2.5% agarose gel is from 31 dB/m to 68 dB/m at 1 MHz. For acoustic 
speed, similar results were measured in muscle (1529 m/s) and 2.5% (w/v) agarose gel 
(1519 m/s to 1560 m/s) (Ortega et al. 2010). Another study (Pilkington et al. 2010) 
showed that thermal conductivity of 1% agarose gel is 0.55 W/m/°C, which is similar to 
muscle (0.618 W/m/°C). Unlike muscle, agarose gel is transparent.  
2) Polyacrylamide gels containing egg white, although they too have similar properties 
to those of muscle, they are not considered in this study as their major component egg 
white causes a colour change from transparent to milky white (Divkovic et al. 2007) 
with rise in temperature caused by ultrasound. 
Agarose gels have been used in studies of drug diffusion and the spread of drugs 
administered by injection. There are reports from Chen  and Ye  describing the 
injection of aqueous and oily dye solutions into 1% (Chen et al. 2008) or 0.5% agarose 
gels (Ye et al. 2012) using injection pumps. In the study by Chen (2008), an injection 
volume of 26 µL aqueous dye was injected at a rate of 0.27 µL/min. In the study by Ye 
(2012), an injection volume of 3 µL oily solution of dye (at injection rate of 
0.3 µL/min) was injected into an 0.5% (w/v) agarose gel. In these studies, the gel 
provided a suitable model of muscle for studying the diffusion of the injected 
formulations. However, the injection volumes employed were much lower than those 
required for studies of IM injections in humans (2 ml) and cattle (5 ml) and much lower 
in injection rate than required in clinical applications (>2 ml/min). Some researchers 
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have attempted to improve the suitability of the model by introducing pre-made cavities 
into phantom gels to create space for the injected formulations (Behrendt et al. 2008, 
Foroughi et al. 2011).  
The frequency of US used in the medical field varies from kHz to MHz. Lower 
frequency US is less attenuated than higher frequency and therefore penetrates tissue to 
greater depths (Gammell et al. 1979). Liu found that US of 1 MHz frequency enhanced 
drug transport and distribution in rat brain (Liu et al. 2010). As regards thermal effect, 
Draper et al. (1995) showed that the temperature of human muscle 30 mm below the 
skin surface increased by 5°C after exposure to 1 MHz, 1.5 W/cm2 US for 10 min 
(Draper et al. 1995).  
For the power of US used on human, an in vivo study in mice indicated it was 
necessary to increase US intensity from up to 3 W/cm2 to achieve increases in the 
temperature of skin and deeper tissue (ter Haar 2007) although other in vivo studies 
showed 1.5 W/ cm2 US was sufficient to  raise the temperature of human muscle tissue 
(Hayes et al. 2004). 
The work described in this Chapter involved (1) the use of a transparent agarose gel 
phantom to visualise the spread of a dye formulation injected into premade cavities 
with and without exposure to US and (2) the application of US using a US device (TSG 
US-7c Canine Ultrasound) commonly used for physiotherapy on dogs.  
2.2 CHAPTER AIMS 
The aims of the work described in this Chapter were the following:  
• to develop an agarose gel system to study the spread of formulations;  
• to determine how the nature of a formulation (aqueous or oily) affects its spread in 
the gel phantom; and  




Analytical grade Nile blue powder was purchased from Sensient Technologies, 
Auckland, New Zealand, Analytical grade Nile red powder was purchased from Sigma 
Aldrich, New Zealand. Granulated agar powder (BD® Difco TM Agar) was purchased 
from BD, USA. Medium chain triglyceride (Miglyol 812N) was purchased from Sasol, 
Hamburg, Germany. Milli-Q water (Millipore Corporation, Bedford, MA, USA) was 
used for gel and dye sample preparation. The US device (TSG US-7c Canine 
Ultrasound) setting with 1.1 MHZ and 3 W/cm2 maximum output was purchased from 
TGS Electronics Pty. Ltd, Australia. 
2.4 METHODS 
2.4.1 Preparation of agarose gel phantom 
Initially, both oily and aqueous dye solutions were injected directly into gels. However, 
with a large injection volume (0.4 mL), most of the injected solution flowed back up 
the needle track and occasionally the gel cracked and caused more leakage. After 
several attempts, it was decided to use gels with premade cavities.  
An agarose gel (1%) with premade cavities was prepared by the following procedure 
(McCabe, 1972). In a beaker, 250 mL Milli-Q water was stirred at 1500 rpm and heated 
to 100°C on a magnetically stirred heating plate (ARE heating magnetic stirrer, VELP 
Scientific). Once the water began to boil, 2.5 g of Agar powder was added with 
continuous stirring until a clear solution was obtained. The solution was then poured 
into a container (length 90 mm, width 65 mm, height 40 mm) for casting and left 
undisturbed at room temperature for 2 h to solidify. Two cavities, each with diameter 
6 mm and depth 20 mm, were produced in the upper surface of the gel during the 
casting by inserting needle caps (BD® PrecisionGlide needle, 21G 1 1/2TW). The 
volume of the cavities was approximately 0.57 mL. The dimensions of the phantom 




Figure 2-1 Dimensions of the agarose gel phantom and the positions and dimensions of 
the two premade cavities. 
After the phantom gel was solid, it was cut into half (shown as red dotted line in Figure 
2-1) so that each half contained one cavity in the top surface of the phantom gel.  
2.4.2 Preparation of dye formulations 
Nile blue solution (0.001% w/w) was prepared by mixing 0.1g Nile Blue powder and 
making up to 10 g Milli-Q water and then diluting (1-1000) to the final concentration 
with Milli-Q water. Nile Red solution (0.01% w/w) was made by mixing 0.1g Nile Red 
powder up to 10 g with Miglyol 812 then diluting to the final concentration with 
Miglyol 812.  
2.4.3 Working cycle of the US transducer   
The US device used in this study had a crystal diameter of 26 mm, a 1.1 MHz working 
frequency and an output intensity range of 0-3 W/cm2. The output of the US wave was 
set to continuous mode and the “off-on” working cycle (WC) to 6 min (Figure 2-2). 













maximum output (3 W/cm2) for the next 6 min. The US was applied for 60 min i.e. for 
5 WC. The reason for a 6 min “off-on” WC was to avoid melting the gel phantom.  
2.4.4 Injection of formulations 
The formulations were designated 1-4 as follows: (1) aqueous solution of Nile Blue 
with US; (2) aqueous solution of Nile Blue without US; (3) oily solution of Nile Red 
with US and (4) oily solution of Nile Red without US. Aliquots of formulations 
(0.4 mL) were injected into the cavities after which the cavities were sealed with US 
coupling gel (AllCare Products Pty Ltd, Auckland, New Zealand). The US probe was 
placed closely connecting to the upper surface of gel in order to apply US to the 
formulations (1 MHz using the 6 min “off-on” WC). 
Images were captured from the side of the gel phantoms using an iPhone 6 camera 
(Apple, USA) placed in a fixed position 20 cm from the gel. Photos were taken every 
6 min over the 60 min of the 5 WC. 
2.4.5 Analysis of spread of injected formulations 
Image analysis was carried out using Image J software (Version 1.49, National 


























Figure 2-2 The 6 mins “off-on” ultrasound (1.1 MHz, 3W/cm2) working cycle. 
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background noise removed and the threshold adjusted to measure the area of interest 
(Figure 2-3). 
a)  b)  
Figure 2-3 a) The original image shows the gel phantom with visible distribution 
pattern of the Nile Blue formulation; b) Processed image - the background was 
removed and turned to black/white image (binary) for measuring the region of interest 
(ROI, shown as red box) 
The spreading area of injection was measured by the Region of interest (ROI) function 
of Image J software. ROI were measured at time 0 then at every 6 min up to 60 min. 
The ratio of changing area of spread were calculated by the following equation: 
% change in the area of spread =  
 𝐴𝑟𝑒𝑎𝑇=𝑛
𝐴𝑟𝑒𝑎𝑇=0
 × 100%  equation 2.1 
where, n = time 0, 6, 12…60 min. The data were then plotted in Excel. More details of 
the image processing are shown in Appendix-1.  
2.4.6 Effect of ultrasound on temperature inside the agarose gel  
A thermocouple (Digitech QM1323, China) was placed inside each cavity to monitor 
the temperature of formulations during experiments. A second thermocouple was 
placed on the bench near gel phantoms to monitor the surrounding temperature. 
Temperature was measured every 6 min, over the 60 min of the 5 WC. 
22 
 
2.4.7 Pore size of agarose gels  
The pore size of agarose gels was measured based on the change in turbidity of their 
clear solutions during solidification (Aymard et al. 2001). Briefly, a clear solution of 
agar (1%, 2% and 3%) prepared as described in Section 2.4.1 was transferred into a 
3 mL glass cuvette and placed in the beam of a UV-Vis spectrophotometer (Ultrospec 
2100 pro spectrophotometer, GE Healthcare, MO, USA). The absorbance was then 
measured every 10 nm in the range 700-800 nm at time zero and every 20 min 
thereafter until a solid gel was formed. The experiment was carried out in triplicate. 
The turbidity and pore size were calculated using Aymard’s method: 
𝜏(𝜆) = 2.3 𝐴(𝜆)/𝐿                                                                            equation 2.2 
where 𝜏 is the turbidity, A is the absorbance, λ is wavelength and L is the optical path 
length. Turbidity spectra were calculated from the absorbance spectra and used to 
calculate the wavelength exponent (WLE) using the equation 
WLE =  
𝑑 log 𝜏(𝜆)
𝑑 log 𝜆
                                                                                 equation 2.3 
The plot (Figure 2-4) of WLE corresponding to pore size values of 1 nm to 100 µm is 




Figure 2-4 Dependence of the wavelength exponent (WLE) calculated between 700 nm 
and 800 nm on the correlation length (Aymard et al. 2001). 
Aymard’s method provides an accurate estimation of the pore size of agarose gels for 
pore sizes in the range 30 nm -2000 nm (Narayanan et al. 2006). Considering the 
typical pore size of agarose gels is in the range 80-500 nm (Pernodet et al. 1997), 
Aymard’s method provides a fast and convenient method for pore size determination. 
2.5 RESULTS 
2.5.1 Analysis of spread of formulations from gel cavities 


















Figure 2-5 Percentage change in area of spread of Nile blue dye in oily and aqueous 
solutions in agarose gel (1%) phantoms  with and without the application of ultrasound 
(data points are means ± SD, n=3). 
A large increase in area of spread (~230%) was observed for the aqueous formulations 
irrespective of the application of US. The rate of spread decreased slightly over time as 
shown by the curvature of the graph. The oily formulations showed no evidence of 
spread both with and without US.  
2.5.2 Effect of US on temperature inside gels 
After exposure to 60 min of off/on US, the temperature of the gel increased from  
20.4°C to 45.5°C in a stepwise manner (Figure 2-6). The rate of increase of temperature 
in successive 6 min on periods tended to decrease slightly. The decrease in temperature 








































Figure 2-6 Increase in temperature of a 1% (w/w) agarose gel during exposure to 
60 min of an off/on ultrasound (1.1 MHz, 3 W/cm2) working cycle (data are 
means ± SD, n = 3; the first 6 min are off). 
2.5.3 Determination of gel pore size 
The agarose gel remained in the liquid state during the first 40 min of cooling in 
cuvettes so no pore size could be measured. The pore size then decreased for gels of all 























Figure 2-7 Pore size of 1%, 2% and 3% agarose gels during the gel solidification 
process (gels were liquid during the first 40 min of cooling). 
 
Figure 2-8 Pore size of 1%, 2% and 3% agarose gels after cooling for 80 min (data are 
means ± SD, n=6 for 1%, n=3 for 2% and 3% gels). 
After cooling for 60 min, agarose gels solidified and stable pore size measurements 
could be obtained. As Figure 2-8 shows, pore size decreased as the gel concentration 
increased. The mean pore size of the 1% agarose gel was around 350 nm with a large 
















































2.6 DISCUSSION  
Before discussing the spread of formulations placed in pre-made cavities in agarose 
gels, it is pertinent to consider the situation during direct injection into a gel phantom. 
In this case the injectate is pushed into the gel to create its own cavity as occurs during 
an IM injection into animal tissue. The elasticity of the gel then works to close the 
cavity and squeeze the injectate out. The routes that liquid flows out will depend on the 
resistances of the various routes of escape. The opposing forces eventually reach a 
balance at which point a small amount of injectate remains in the gel as a depot and the 
rest returns to the tissue surface through the injection hole. This series of events has 
been observed in animal studies. For example, injection of 200 µL of an oily solution 
into the caudal thigh muscle of mice was followed by massive leakage to the outside of 
the targeted muscle bundle (Gehling et al. 2018). The result reveals that the elasticity of 
muscle is more than sufficient to eject all but a small volume of an IM injection.  
In experiments involving injection into premade cavities in gel phantoms, a major 
drawback of the method is that the injectate is not under pressure when introduced into 
the cavity. Therefore there is no pushing force to counteract the elasticity of the gel and 
facilitate spread. In fact the spreading shown in Section 2.5.1 is actually the result of 
diffusion of the dye into the gel matrix and not a true reflection of spread. However, the 
terms “spread” and “area of spread” are still used here for the sake of consistency.  
Interestingly, the results obtained for injection of aqueous and oily solutions are very 
different. Of particular interest is the fact that there was no spreading of the oily 
solution even after 60 min. This is consistent with the findings of Larsen et al. 2001 
who showed that the clearance of an oily vehicle from injection site can take from 
hours to days. In our experiment, the absence of spread from the oily solution can be 
ascribed to the insolubility of Nile red in water and its inability to partition from the oil 
into the aqueous phase of the matrix of the gel. In contrast, the spreading of the water 
soluble Nile blue dye into the agarose gel requires no phase transfer and occurs 
efficiently irrespective of the application of US.  
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Based on the work of Zuidema et al (1988), diffusion plays an important role in the 
absorption of drugs when aqueous solutions are administered by IM injection. The 
diffusion coefficient is defined as follows: 
𝐷 = 𝐷0𝑒
−𝐸𝐴/𝑘𝑇                                                                                            equation 2.4 
where D0 is the maximum diffusion coefficient at infinite temperature, EA is the 
activation energy T is the absolute temperature and k is the Boltzmann constant. Since 
in the experiments described here D0, EA and k are constants, the relationship between e 
and D can be simplified to: 
𝐷 ∝ 𝑒−
1
𝑇                                                                                                        equation 2.5 
Given that T refers to absolute temperature, it is clear that D does not change a great 
deal for the temperature increase of 25°C resulting from the application of US to the 
gel.  
While the temperature change has little effect on diffusion, this is not the case for pore 
size which is critical for the absorption of an IM injection. The pore size of the 1% agar 
gel used in this study of 340 ± 75 nm is within the range reported in previous studies. 
According to the results of a study by Pluen et al,1999 molecules with a hydrodynamic 
radius < 30 nm have little or no interaction with the gel matrix(Pluen et al. 1999). Since 
the hydrodynamic radius of Nile blue is only about 0.5 nm (Dutt et al. 1991), it is clear 
it does not interact with the polymer matrix of the phantom gel and spreads without 
resistance. Thus although the increase in temperature has the potential to increase pore 
size (Aymard et al. 2001), its influence on the spread of Nile blue is also negligible. For 
the oily solution where the Nile red must first partition into the aqueous gel before 
undergoing diffusion(Larsen et al. 1998), the small temperature increase will cause only 
a negligible change in its partition coefficient. Also, the temperature increased by US, 
as observed in gel experiment, is not likely to occur in vivo since heat would dissipate 
into the flowing blood.  
In summary, the study of the spread of dyes from aqueous and oily injectates into 
phantom gels was restricted to the use of premade cavities. This did not reflect the true 
29 
 
situation of IM injections which are administered under pressure. Only dye in aqueous 
solution showed apparent spread which occurred by diffusion and was not affected by 
the application of US despite the increase in the temperature of the gel it caused. 
Further work will be restricted to studies of spread subsequent to IM injections into the 









CHAPTER THREE  
EFFECT OF US ON THE SPREAD OF  
INTRAMUSCULAR INJECTIONS IN PORCINE 





Following an IM injection, the injectate spreads from the site of injection and is 
subsequently absorbed into the peripheral circulation. Characterizing the spread 
depends on understanding the nature of the formulation, selecting an appropriate tissue 
model and developing a technique to measure the spread. Only a few studies have been 
done about quantifying the spread of IM injections. One group injected iohexol into 
thigh muscle of mice (injection volume up to 200 μL), then the spread of injection was 
measured by coned beam computed tomography (CT) (Gehling et al. 2018). However, 
there are drawbacks to the use of small animals such as their small body mass, large 
ratio of injection volume to muscle mass and differences in physiological factors from 
those in large mammals. Accordingly, sheep were used in this study to better 
understand the pattern of spread of IM injections in large livestock animals. In this 
chapter, formulations were IM injected immediately after euthanasia of sheep. The fact 
that blood flow and muscle movements are absent in the dead animal is a limitation of 
this method.  
A major challenge in researching the spread of IM injectates lies in choosing an 
appropriate imaging technique. This is mainly because of the scarcity of relevant 
literature. However, a recent study showed that CT could be used to examine the spread 
of aqueous formulations containing an iodinated, water soluble contrast agent 
(Dauffenbach et al. 2014). Application of the technique to study the spread of IM 
injections in unembalmed corpses showed that detailed images could be obtained with 
sufficient resolution to delineate the spreading pattern. CT imaging was therefore used 
in the present study to examine the effect of US on the spreading behaviour of oily 
formulations after IM injection into the muscle of post-mortem sheep. In this chapter, 
preliminary study-I was carried out firstly to prove the concept of US affecting the 
spread of IM injected formulations by injecting aqueous and oily formulation 
containing fluorescent dye in porcine muscle (Section 3.4.1). After the concept was 
tested, preliminary study-II was carried to determine the suitable type and concentration 
of contrast agent for CT scans (Section 3.4.2). In Section 3.4.3, The experiment on 
post-mortem sheep was then carried out. The statistical analysis of the post-mortem 
sheep study data is described in Section 3.4.4. Particle size and viscosity of the 
formulation used in post-mortem experiments were also analysed (Section 3.4.5). 
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Characteristics of muscle dissected from around the injection site (Section 3.4.6) and 
surface temperature (Section 3.4.7) were recorded as well.   
3.2 Chapter aims 
The aims of the research reported in this Chapter were to determine: 
• the effects of US on the spread of formulations injected into a piece of porcine 
muscle; and  
• the effects of US on the spread of formulations injected into the muscle of post-
mortem sheep (wethers). 
3.3 Materials 
Materials [suppliers] were as follows: MF-fluoRed (particles) [Microparticles GmbH, 
Germany]; Nile blue powder and MilliQ water [see Section 2.3.1]; Boneless cuts of 
porcine muscle (300 g each) were purchased from a local supermarket. Lipiodol® 
(ethyl esters of iodized fatty acids of poppy seed oil containing 48% w/v iodine, NDC 
67684-1901-1) [Guerbet, USA], barium sulfate (analytical grade) and Oil Blue N dye 
[Sigma-Aldrich, New Zealand], Miglyol 812 [Sasol, Hamburg, Germany], Cremophor 
EL [BASF, Germany], Maisine 35-1 (glyceryl monolinoleate) [Gattefosse, France].  
3.4 Methods 
3.4.1 Preliminary study I: Spread in porcine muscle phantoms 
3.4.1.1 Formulations 
The aqueous formulation was an 0.001% (w/w) solution of Nile blue in MilliQ water. 
The oily formulation was a suspension of MF-FluoRed (0.1% w/w) prepared by adding 
0.1 g MF-FluoRed to 100 g Miglyol 812. Formulations were mixed well by vortexing 
for 1 min (IKA® Minishaker, Sigma-Aldrich, New Zealand).  
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3.4.1.2 Experimental setup 
The spread of IM injections in porcine muscle phantoms was visualized using a Bruker 
FX pro imager (Bruker, USA), an automated multifunctional imaging platform. 
Fluorescence images detecting the dyes were obtained using excitation and emission 
wavelengths of 630 nm and 790 nm. In each experiment, two pieces of porcine rump 
muscle were placed in the FX pro imager as shown in Figure 3-1. One piece was treated 
with US while the other acted as control.  
 
Figure 3-1 Image of two pieces of porcine rump muscle (1 & 2) in the FX pro imager.  
Muscle 1 (control) was not exposed to US whereas Muscle 2 (test) was exposed at the 






Aqueous and oily formulations were studied in separate pieces of muscle each with a 
respective control. Aliquots of 0.5 mL and 0.3 mL of aqueous and oily formulations 
respectively were injected into muscle. In both cases a 1 mL syringe (needle size 
21G 1 1/2 TW) was used to deliver injectates to a depth of 15 mm below the muscle 
surface. Test muscle was then exposed to 3 min, 1 MHz 3 W/cm2 US, 100% duty cycle 
at the injection site. Images were captured immediately after injection and at the end of 
the US application. Captured images were analyzed using FX image pro software.  
3.4.2 Preliminary study II: Contrast agent concentration in the post-mortem sheep study 
3.4.2.1 Formulations:  
To determine the most suitable concentration of contrast agent in formulations to be 
studied in the post-mortem sheep study, a series of solutions and suspensions of the 
contrast agent were prepared. Lipiodol concentrations of 24% and 12% were prepared 
by diluting the commercial 48% solution with Miglyol. Barium sulfate powder (1, 2, 3 
and 4 g respectively) was added into Miglyol 812 (10 g final weight) to make 10%, 
20%, 30% and 40% (w/w) barium sulfate suspensions. Oil blue N dye (0.02% w/w) 
was added to each formulation. The criteria for the most suitable concentration of 
contrast agent included ease of injection, lack of interaction with the Oil blue N dye, 
good contrast of muscle. 
3.4.2.2 Experimental setup 
Formulation spread was evaluated by FX pro imager (Bruck Corporation, USA) based 
on observations of 4 x 0.1 mL IM injections into sheep muscle (lamb loin chops with 
80g of average weight from local supermarket) using a 21G 1 1/2TW sized needle. The 
needle was left inside the muscle after injection to indicate the site. Each concentration 
was tested in duplicate.  
3.4.3 Spread in post-mortem sheep 
3.4.3.1 Preparation of formulations 
There were three different formulation types used in post-mortem experiment: oily 
solution, oily suspension and self-emulsifying system (SEDDS). 
Lipiodol at original concentration (48%, w/v) was used as oil soluble contrast.  
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The oily contrast suspension (30% w/w) was prepared by adding barium sulfate (30 g) 
to Miglyol 812 (70 g) with continuous stirring on a magnetic stirrer set at 550 rpm. 
Stirring of the suspension was then continued for 30 min to achieve homogeneity after 
which the suspension was milled in a planetary ball mill (Retsch® Planetary Ball Mill 
PM 200, Germany) using zirconium oxide beads (1 mm) and a zirconium oxide milling 
jar (4 kg). The operating protocol involved a total milling time of 40 min at 400 rpm 
with 5 min intervals and 2 min breaks. 
The SEDDS was prepared by mixing Lipiodol, Maisine and Miglyol 812 in the ratio 
40:20:40 w/w on a magnetic stirrer (ARE heating magnetic stirrer, VELP Scientifica) 
set at 550 rpm for 10 min.  
3.4.3.2 Animals 
Experiments were carried out in July 2015 using 3 male wether lambs (age 6 months-
8 months; weight 32 kg). The animals had free access to food and water and were 
housed in a pen at the animal facility of AgResearch NZ, Invermay Agricultural Centre, 
Dunedin. Euthanasia was carried out by injection of sodium pentobarbital (Pentobarb 
300 (300 mg/mL), Sigma-Aldrich, New Zealand) at a dose of 100 mg/kg-150 mg/kg.  
All procedures involving sheep were approved by the University of Otago Animal 
Ethics Committee (Approval Number: 36/15, 19 June 2015).  
3.4.3.3 Experimental design 
3.4.3.3.1 The design of analysing US effect on spread.  
In the post-mortem sheep experiment, the effects of different formulation types, 
injection volume and US exposure time were studied by a balanced factorial design. 
The levels of the factors are listed in the following table:   
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Table 3-1 Factorial design of US impacted spread.  
Factor Factor level 
 Low  Centre High 
Formulation type (F) Solution  Suspension SEDDS 
Injection volume (V) 1.5 mL N/A  4.5 mL 
US duration (U) 0 min 5 min 10 min 
In total, there were 3x3x2=18 different combinations of levels and factors. Each 
combination was tested as duplicated, the total injection number was 36. The 36 
injections were randomly assigned to the backs of three sheep and the rumps of the 
same three sheep as shown in Figure 3.2 and Table 3.2. Thus back and rump were two 
blocks. Three levels of US treatment (0, 5 or 10 min) were then randomly assigned to 
each formulation-volume combination in a balanced fashion (see Table 3.2) 
 
Figure 3-2 Block design and injection sites 
Sheep1 Sheep2 Sheep3 
Block 1 
Block 2 
Back Back Back 
























































1 Solution 1.5 0 B17 R04 
2 Solution 1.5 5 B09 R09 
3 Solution 1.5 10 B05 R13 
4 Solution 4.5 0 B07 R18 
5 Solution 4.5 5 B04 R10 
6 Solution 4.5 10 B13 R03 
7 Suspension 1.5 0 B14 R11 
8 Suspension 1.5 5 B11 R12 
9 Suspension 1.5 10 B08 R06 
10 Suspension 4.5 0 B02 R02 
11 Suspension 4.5 5 B15 R16 
12 Suspension 4.5 10 B18 R15 
13 SEDDS 1.5 0 B12 R01 



















15 SEDDS 1.5 10 B03 R05 
16 SEDDS 4.5 0 B10 R07 
17 SEDDS 4.5 5 B06 R08 
18 SEDDS 4.5 10 B01 R17 
In this design, due to the duplicated test was on a different block (back vs rump), the 
difference between blocks was tested. The ANOVA design for US impact on spread is 
shown in Table 3-3:  
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Table 3-3 Design of ANOVA for US impacted spread  
Factor Degree of freedom 
Formulation 2 
Injection volume 1 
US duration 2 
Block 1 
Formulation x Injection volume 2 
Formulation x US duration 4 
Injection volume x US duration 2 
Formulation x injection volume 




From literature, interactions with block are included within the error term 
3.4.3.3.2 The design for analysing initial spread 
Initial spread was assessed by carrying out CT scans soon after (see Table 3.7 for 
timings) all injections listed in Table 3-2 were finished, but before any application of 
US. Thus the factors involved in the analysis of initial spread were formulation type 




Table 3-4 Factorial design of initial spread  
Factor Factor level 
 Low  Centre High 
Formulation type (F) Solution  Suspension SEDDS 
Injection volume (V) 1.5 mL N/A  4.5 mL 
There were totally 3 x 2 = 6 combinations of factors and levels. The randomly 
assignment of injection site is shown in Table 3-5 which is the same as Table 3-2 but 
without the column of US exposure duration.  
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Each combination was tested six times. The total number of injections (36) was divided 
into two blocks, one block being the back of three sheep and the other block being the 
rump of the three sheep. The analysis of variance (ANOVA) of initial spread is shown 
in Table 3-6:   
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Table 3-6 Design of ANOVA for initial spread  
Factor Degree of freedom 
Formulation 2 
Injection volume 1 
Block 1 
Formulation x Injection volume 2 
Error 29 
Total 35 
From literature, interactions with block are included within the error term.  
3.4.3.4 IM injection protocol 
Following euthanasia, the carcasses were fixed on a moveable operating table and the 
entire rumps and backs shaved in preparation for IM injections. A total of 12 injections 
were made into each carcass (6 in the rump and 6 in the back) using BD® 5 mL 
Tuberculin Syringes and BD® PrecisionGlide needles (21G 1 1/2TW). Injections were 
made 10 min after euthanasia at an angle of 90° to skin surface and a depth of 25 mm. 




Figure 3-3 The location of the 12 injections in the rump (6) and back (6) muscles of a 
post-mortem sheep. 
A summary of the procedures and the timeline involved is given in Table 3-7. 
Table 3-7 Timeline for each sheep in the post-mortem experiment  
Time (min) Event (for each sheep) 
0  Animal euthanasia and shave 
10 Total 12 IM injections, 6 on back and 6 on rump 
20 Injection finished, start the 1st CT scan 
30 1st CT scan finished, start US treatments 
65 All US treatments finished 
70 2nd CT scan starts 
There were three levels for US duration: 0, 5 and 10 min. But the gap between the 1st 





treatments. The reason is during the experiment, there were only two US transducers 
available so it was impossible to carry all 12 treatments simultaneously. In order to 
keep the gap between two CT scans the same, the 2nd CT scan was set 40 min after the 
1st one. This procedure means for 0 min US group, during the 40 min gap between two 
CT scans, the IM injected formulation received 0 min US treatment. For the 5 and 10 
min US groups, they received 5 and 10 US treatment, respectively, during the same 
time period. 
3.4.3.5 CT imaging and US protocol 
Following IM injections, animals were moved to the CT scanner (GE Lightspeed CT 
Scanner, General Electric, USA). Two rounds of whole body CT scan were applied to 
each animal. Each CT scan captured a series of images of various positions in a 
transverse plane. The distance between each image slice was 1.25 mm.  
First an image was captured showing the general condition of spread of the injected 
formulations in the whole animal in the sagittal plane. Subsequently the first whole 
body CT scan was carried out to capture the situation before US treatment and provide 
a measure of the initial spread. The term “initial spread” used here is of passive spread 
of injectate, that is prior to application of US. Then US was applied for various times 
(0, 5 or 10 min) to the injection sites using a TGS-7c Ultrasound Device (TGS 
Electronics Pty. Ltd, Australia). The surface temperature before and after exposure to 
US was also recorded using an infrared laser thermal detector (Mini IR Thermometer 
42500, Extech, USA).  
After US application, sheep were subjected to the second whole body CT scan in the 
transverse plane to capture the resulting spread pattern.  
3.4.3.6 CT image analysis 
CT images were imported into ImageJ (version 1.50b) software for analysis. The 
images in the transverse plane were sorted as an image sequence for each pair of 
injections. Each image slice of 250 mm x 250 mm had 512 x 512 resolution which is 
approximately 0.48 x 0.48 mm/pixel.  
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First, all slices in the transverse plane were stacked up by a plugin 3D viewer of ImageJ 
to rebuild an image in the 3D mode. Each image slice in the transverse plane was 
processed by adjusting the threshold to reduce the signal from muscle. Then the whole 
image sequence was adjusted to 8-bit images. Next, areas of bone in the images were 
manually coloured black. Finally, the contrast from the injected formulation was the 
only visible part in the image allowing its area to be measured by ImageJ. The areas in 
each image slice were summed and multiplied by the distance between each slice to 
calculate the volume of spread Vspread using Equation 3.1: 
𝑉𝑠𝑝𝑟𝑒𝑎𝑑 = ∑ 𝐴𝑟𝑒𝑎𝑒𝑎𝑐ℎ 𝑠𝑙𝑖𝑐𝑒 × 1.25 (𝑚𝑚
3)                                               Equation 3.1 
Here Areaeach slice is the area (mm
2) of the contrast pattern in each CT slice and 1.25 mm 
is the distance between each slice. The percentage increase in volume of spread 
between two CT scans is given by Equation 3.2.  
Ratio =
𝑉𝑠𝑝𝑟𝑒𝑎𝑑 2𝑛𝑑 𝐶𝑇 𝑠𝑐𝑎𝑛
𝑉𝑠𝑝𝑟𝑒𝑎𝑑 1𝑠𝑡 𝐶𝑇 𝑠𝑐𝑎𝑛
× 100%                                                            Equation 3.2 
3.4.4 Statistical analysis 
Data were analyzed using two-way analysis of variance (two-way ANOVA) in Minitab 
software (version 17.0). The factorial design of the ANOVA was first to identify any 
difference in the initial spread associated with injection volume and type of 
formulation. Secondly, the ANOVA determined any difference in the increase in spread 
resulting from US exposure time, injection volume and formulation type. Post-hoc 
analysis was performed using the Tukey test and statistically significant differences 
were those for which p ≤ 0.05. 
3.4.5 Characterization of the formulations for post-mortem study 
3.4.5.1 Determination of particle size of the oily suspension  
The particle size of original barium sulfate suspension (from Section 3.4.3.1) was 
unable to be measured as it was too cloudy. In order to dilute the suspension without 
changing the particle size, saturated barium sulfate in Miglyol 821 was prepared. 
Excess barium sulfate was added to Miglyol 812 (100 ml) and stirred overnight to make 
a saturated solution. It was then allowed to settle for 1 h and the supernatant transferred 
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to a glass vial. An aliquot (0.5 mL) of milled 30% barium sulfate suspension (from 
section 3.5.1) was diluted 1:100 by adding 49.5 mL barium sulfate-saturated Miglyol 
812.  
The diluted barium sulfate suspension was filled into the quartz sample container 
(fraction cell) of the laser diffraction particle size analyser (Horiba Instruments, Irvine, 
CA). The relative refractive index was set at 1.44 (Cable, 2012) and the cell 
recirculation speed at 2. Samples were prepared in duplicate and results were the mean 
of at least 10 measurements. 
3.4.5.2 Rheology of suspension and SEDDS 
The viscosities of the barium sulfate oily suspension and SEDDS were measured in 
triplicate using a TA rheometer HR3 (TA instruments, U.S.A) with cone-plate 
geometry (Cone SST ST 60MM 2DEG SAMRT-SWAP, ref. 996902). The shear stress 
and viscosity of samples were measured at increasing shear rate (ramp up) from 0 s-1 to 
200 s-1 followed by measurements at decreasing shear rate (ramp down) from 200 s-1 to 
0 s-1. The test duration was 480 s. The temperature of tests was set at 37°C and 42°C. 
Data were recorded every 3 s.  
3.4.6 Dissection of muscle to study spread 
Approximately 2 hours after the second CT scan, dissection of sheep muscle at the 
injection sites was carried out in the Department of Anatomy, University of Otago. The 
whole back and rump muscles were dissected into pieces each containing at least one 
injection site and then snap frozen in liquid nitrogen. Frozen muscle was then stored at 
-85°C until processed seven months later. The frozen muscle pieces were then cut into 
cross-sectional slices approximately 15 mm thick and the spread pattern (dye) captured 
using an Iphone 6 camera (Apple, USA).  
3.4.7 Effect of US on muscle temperature 
A piece of lamb rump (100 mm x 50 mm x 50 mm) with skin (4 mm) and a thin layer 
of wool was obtained from a local butcher and fixed in a plastic container with skin 
side up. The container had two openings, one on top for the US probe and another on 
the side for thermocouples (Digitech QM1323, China) placed at various depths (4, 20 
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and 30 mm) below the skin surface (Figure 3-2). US (1. MHz, 3 W/cm2, 10 min 
continuous) was applied and the surface temperature measured at 0, 10, 15 20, 25, 30 
and 35 min using an infrared laser thermal meter (Mini IR Thermometer 42500, Extech, 
USA). Thermocouples measured temperature at various depths every minute for the 
first 15 min and then every 5 min up to 35 min.  
3.5 RESULTS 
3.5.1 Preliminary study I: Spread in porcine muscle phantoms 
The effect of US on the spread of an aqueous solution of Nile blue dye injected into 
porcine muscle was assessed using fluorescence imaging. The site of injection was 
marked by a bright fluorescent spot the intensity of which was constant over a 10 min 
period. Following the application of US, the brightly labelled spot dissipated and the 
area covered by dye within muscle increased (Figure 3-4) indicating spread. 
 
Figure 3-4 Effect of US on the spread of an aqueous solution of Nile blue dye (0.5 mL 
0.001% w/w) injected into a porcine muscle phantom and imaged with an FX pro 
imager. The control site (top) was left undisturbed while the test site (bottom) was 
exposed to US (1.1 MHz, 3 W/cm2 for 3 min, 100% duty cycle). 
















The effect of US on the spread of an oily suspension within porcine muscle was 
assessed using fluorescent imaging of MF-FluoRed particles (0.1% w/w). As shown in 
Figure 3-5, the oily formulation did not spread outward from the initial site of injection 
in control tissue. After exposure to US, the fluorescent spot disappeared but the nearby 
edge of the tissue was illuminated. Whether this is indicative of spread is complicated 
by the proximity of the muscle boundary.  
 
Figure 3-5 Effect of US on the spread of fluorescence labelled particles in an oily 
suspension (0.3 mL 0.1% w/w) injected into a porcine muscle phantom and imaged 
with an FX pro imager.. The control site (top) was left undisturbed while the test site 
(bottom) was exposed to US (1 MHz, 3 W/cm2 for 3 min on 100% duty cycle). 
3.5.2 Preliminary study II: Contrast agent concentration in the post-mortem sheep study 
Figure 3-6 shows the results of injecting formulations (0.1 mL of injection volume with 
2 cm of injection depth) containing various concentrations of contrast agents into four 
pieces of sheep muscle (10 x 8 cm in size). The Figure shows that Lipiodol (48% w/v) 
provides the most intense contrast which is sufficient to distinguish it from muscle and 
bone. For the barium sulfate suspension, both the 30% and 40% concentrations are 
distinguishable from muscle but the 40% suspension was too viscous to allow facile 
delivery from the syringe. The presence of Oil Blue dye (meats 3 and 4) did not 
interfere with the contrast displayed by both Lipiodol and barium sulfate.  
Test 
Test  
Control  Control  





Figure 3-6 Pieces of lamb loin chops injected with oily formulations containing various 
concentrations of Lipiodol and barium sulfate contrast agents together with Oil Blue 
dye. The needles used for injection were left in the muscle to identify the injection sites. 
3.5.3 Spread in post-mortem sheep 
Figure 3-7 shows a CT scan of the spread of formulations containing contrast agents 
injected into the rump and back muscle of a post-mortem sheep. The formulations 




Figure 3-7 General condition of spread of formulations containing contrast agents 
injected into the back muscle (red box) and rump muscle (blue box) of a post-mortem 
sheep as observed by CT scan in the transverse plane. 
3.5.3.1 Initial spread of oily formulations 
The initial spread was the volume of spread of the injected formulations in the post-
mortem sheep after 10 min calculated using Equation 3.1. The results from ANOVA of 
initial spread are shown in the Fig 3-8, Fig 3-9 and Table 3-8: 
 





Figure 3-9 Interaction plot (formulation x injection volume) for initial spread.  
Table 3-8 ANOVA for initial spread  
Source DF Adj SS Adj MS F-valve P-value 
Formulation 2 29809510 14904755 0.74 0.488 
Injection volume 1 21840044 21840044 1.08 0.307 
Block 1 2150133 2150133 0.11 0.747 
Formulation x Injection volume 2 5018098 2509049 0.12 0.884 
Error 29 586905530 20238122   
Lack-of-fit 5 150644437 30128887 1.66 0.183 
Pure 24 436261093 18177546   
Total 35 645723315    
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There was no significant difference (p>0.05) in the volume of spread between 
formulations, injection volumes and blocks. The p-value for block (back vs rump) of 
0.747 meaning there was no significant difference between back and rump and in future 
studies blocking in this way would be unnecessary. The interaction plot (Fig 3-9) 
showed non-parallel lines suggesting an interaction between injection volume and 
formulation type; however the interaction was not significant (P = 0.884). Although the 
mean square values for factors were large, they were not significant because of the high 
variability of the data. The mean square value of error in Table 3-8 suggested high 
variation of volume of spread of IM injected formulations. The full ANOVA report of 
initial spread is attached as Appendix-2. 
Since there is no significant difference between blocks, the data from back and rump 
were combined then each combination of F x V had six repeats. The volume of spread 
for injections of the 1.5 mL was in the order SEDDS > suspension > solution but the 
differences were again not significant (p>0.05) (Figure 3-10) 
 
Figure 3-10 Initial spread of intramuscular injections of different formulations (1.5 mL) 
obtained from the 1st CT scan (data are means ± SD, n=6). 
Similarly there was no significant difference (p>0.05) in the spread of the 4.5 mL 
































Figure 3-11 Initial spread of intramuscular injections of different formulations (4.5 mL) 
obtained from the 1st CT scan (data are means ± SD, n=6). 
3.5.3.2 Effect of US on the ratio of change in volume of spread  
The ratio of the volumes of spread of the 2nd to the 1st CT scan was calculated using 
Equation 3.2. As described in Section 3.4.3.4, the time between the two CT scans was 
around 40 min. The results from ANOVA analysis are shown in Fig 3-12, Fig 3-13 and 
Table 3-9. 
 






























Table 3-9 ANOVA for US impacted spread 
Source DF Adj SS Adj MS F-value P-value 
Formulation 2 2161.9 1080.95 21.84 0.000 
Injection volume 1 1166.2 1166.22 23.57 0.000 
US duration 2 8357.6 4178.80 84.45 0.000 
Block 1 150.1 150.06 3.03 0.100 
Formulation x Injection volume 2 42.3 21.16 0.43 0.659 
Formulation x US duration 4 1555.8 388.95 7.86 0.001 
Injection volume x US duration 2 185.4 92.69 1.87 0.184 
Formulation x Injection volume x 
US duration 
4 552.9 138.23 2.79 0.060 
Error 17 841.2 49.48   
Total 35 15013.4    
Significant differences (p≤0.05) were observed across all three factors: formulation 
type, injection volume and US exposure time. The only significant interaction is the 
formulation x US durations. However, there were no significant differences for the 
interactions between formulation type and injection volume, injection volume and US 
exposure time nor for the interaction between formulation type, injection volume and 
US exposure time (p=0.060). The p-value for block (back vs rump) of 0.100 meaning 
there was no significant difference between back and rump and in future studies 
blocking in this way would be unnecessary. The detailed data of ratio of volumes of 
spread of each formulation were attached in Appendix-3.  
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3.5.4 Post-hoc statistical analysis: Tukey’s test 
The adjusted p-values from post-hoc Tukey’s tests are shown in the Table 3-10. There 
was no significant difference across all combinations between injection volumes and 
US exposure times on the spread of oily solution. Details of Post-hoc statistical analysis 
report was attached in Appendix-4.  
On the other hand, US significantly (p<0.05) enhanced the spread of oily suspensions 
and SEDDS. For the 1.5 ml injection of the oily suspension, exposure to US for 5 min 
did not affect spread but exposure for 10 min significantly increased spread of both oily 
suspensions (p = 0.0025) and SEDDS (p = 0.0011).  
For the 4.5 mL injection of the oily suspension, exposure to US for 5 min significantly 
increased spread (p = 0.0186). However, exposure to US for 10 min did not lead to any 
further increase in spread (p>0.05). For the 4.5 mL injection of SEDDS, exposure to 
US for 5 min increased spread significantly (p = 0.0073) and increase in exposure to 
10 min resulted in a further increase in spread (p = 0.001). 
Table 3-10 Adjusted p-values from post-hoc Tukey’s test 
Formulation type & 
injection volume 




Solution 1.5 mL 0 min vs 5 min 0.9907 N 
0 min vs 10 min 0.3842 N 
5 min vs 10 min 0.9846 N 
Solution 4.5 mL 0 min vs 5 min 0.4141 N 
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Formulation type & 
injection volume 




0 min vs 10 min 0.1399 N 
5 min vs 10 min 1 N 
Suspension 1.5 mL 0 min vs 5 min 0.1321 N 
0 min vs 10 min 0.0025 Y 
5 min vs 10 min 0.7746 N 
Suspension 4.5 mL 0 min vs 5 min 0.0186 Y 
0 min vs 10 min 0.1756 N 
5 min vs 10 min 0.9964 N 
SEDDS 1.5 mL 0 min vs 5 min 0.4003 N 
0 min vs 10 min 0.0011 Y 
5 min vs 10 min 0.1822 N 
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Formulation type & 
injection volume 




SEDDS 4.5 mL 0 min vs 5 min 0.0073 Y 
0 min vs 10 min 0.0001 Y 
5 min vs 10 min 0.0079 Y 
3.5.5 Characterization of the formulations for post-mortem study 
3.5.5.1 Particle size of the oily suspension 
The mean particle size of 30% barium sulfate suspension was 13.8 ± 0.01 μm (D90 = 
30 μm).  
3.5.5.2 Rheology characterization 
For rheological measurements, different shear rates were applied to simulate the shear 
stress during storage (1 s-1 on standing), on mild shaking before injection (10 s-1) and 
during injection itself (100 s-1). Figs 3-14 and 3-15 show the dependence of shear stress 
on shear rate at 37°C and 42°C for 30% barium sulfate suspension and SEDDS 
respectively. Table 3-11 shows the viscosities for barium sulfate suspension and 




Figure 3-14 Dependence of shear stress on shear rate for an oily suspension  of 30% 
(w/w) barium sulfate at 37°C and 42°C. Ramp up and ramp down of shear rate is shown 
as solid and dashed lines respectively. 
The plots of shear stress vs shear rate for the 30% (w/w) barium sulfate oily suspension 
tentatively suggest plastic or pseudoplastic behaviour. The curves do not pass through 
the origin but rather intersect the shear stress axis at around 5 Pa which can be taken as 
the yield point. Above the yield point, the curves are indicative of pseudoplastic flow. 
The ramp up and ramp down curves overlap. The similarity of the curves at 37°C and 
42°C indicate temperature has only limited influence on the rheological properties of 































Figure 3-15 Dependence of shear stress on shear rate for an oily suspension of SEDDS 
at 37°C and 42°C. Ramp up and ramp down of shear rate is shown as solid and dashed 
lines respectively 
As shown in Figure 3-15, the shear stress-shear rate plots for SEDDS at both 37°C and 
42°C are indicative of Newtonian flow behaviour. The ramp up and ramp down curves 
overlap. No thixotropy was detected. Again, the influence of temperature was limited.  
Determination of viscosity revealed the barium sulfate suspension shows high viscosity 
at low shear rate (Table 3-11) and decreasing viscosity as shear rate increased. There 
was no significant difference in viscosity at the two temperatures. The viscosity of 






























Table 3-11 Viscosities of oily suspensions of 30% (w/w) barium sulfate and SEDDS at 
different shear stresses and temperatures (data are means ± SD, n=2). 
Barium sulfate oily suspension (30% w/w) 
Shear rate (s-1) Viscosity (Pa.s) at 37°C Viscosity (Pa.s) at 42°C 
1 4.01 ± 0.12 3.90 ± 0.09 
10 0.87± 0.06 0.87 ± 0.05 
100 0.16 ± 0.01 0.16 ± 0.02 
SEDDS 
Shear rate (s-1) Viscosity (Pa.s) at 37°C Viscosity (Pa.s) at 42°C 
1 0.05 ± 0.01 0.04 ± 0.02 
10 0.03± 0.01 0.02 ± 0.01 
100 0.03 ± 0.00 0.02 ± 0.00 
 
3.5.6 Post-mortem dissection of rump and back muscles 
In total 83 pieces (5 cm x 5 cm x 2 cm) of muscle were collected from the rump and 
back of post-mortem sheep. Initially, the purpose of the study was to calculate the 
volumes of spread and compare them with the volumes of spread obtained in the CT 
scan study. However, due to the difference in the thickness (1.25 mm) of the CT slices 
and manually cut slices (15 mm), it was not possible to match the volumes of spread 
measured by the two techniques. Therefore the spreading patterns based on cross-
section of each slice were photographed and analyzed.  
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Based on the observed spreading patterns at the injection site, the spreading patterns 
could be divided into three types: Spread pattern A where spread was confined to a 
restricted area; spread pattern B where the formulation spread along the fascial sheaths 
of the muscles; and spread pattern C where the formulation mainly spread along the fat 







Figure 3-16 Spreading patterns observed by dissection of injection sites in muscle from 
post-mortem sheep. (a) Spread of 1.5 ml injection of 30% barium sulfate suspension 
containing oil blue dye (0.01%)); spread is mainly within the muscle bundle and 
confined to a restricted area. (b) Spread of 1.5 mL Lipiodol containing oil blue dye 
(0.01%); spread is outside the muscle bundle along the sheath. (c) Spread of 4.5 mL 
Lipiodol containing oil blue dye (0.01%); dye accumulated in fat layer between the 
muscle bundles. 
The three types of spreading patterns (Figure 3-16) were found in both rump and back 
muscle of post-mortem sheep and across all factors (formulation type, injection volume 
and US exposure time). 
Figure 3-17 shows a comparison between the spread observed after dissection and the 
image obtained by CT scan. Spread observed after dissection (Figure 3-17a) is mainly 
along the fascial sheaths and confined in a muscle bundle. Spread observed in the CT 





Figure 3-17 Spread of an IM injection of an oily suspension of SEDDS (4.5 mL) 
containing Oil Blue dye observed (a) after dissection and (b) by CT scan where the red 
arrow indicates the area of spread. 
This result suggests the resolution of the CT imaging system (0.48 x 0.48 mm per pixel) 
is not sufficient to distinguish spread along the primysial and epimysial septae.  
3.5.7 Measurement of thermal response to US in muscle phantom 
Figure 3-18 and Table 3-12 show the temperature rise in response to US at the surface 
and at various depths from the surface in the sheep rump muscle phantom with and 







Figure 3-18 Effect of US (3 W/cm2, 1.1 MHz, 10 min) on temperature rise at the 
surface and at various depths from the surface of a sheep muscle phantom with skin 
attached (data are means ± SD, n=9 for surface, n=3 for below surface). 
The temperature at the surface of rump muscle with skin attached (Figure 3-18) 
increased by 36°C from 24.6 ± 1.3°C to 60.9 ± 2.6°C. At a depth of 4 mm from the skin 
surface, the temperature increased by 28°C; at depths of 20 mm and 30 mm which are 
representative of the depths to which injectates were delivered, only a rise of ~5°C was 
observed.  
The temperature on the skin surface of sheep used in the post-mortem study exposed to 
US (1 MHz, 3 W, 100% duty cycle, 10 min) was also recorded. The results show that 

































Table 3-12 Surface temperature after US exposure (1MHz, 3W, 10 min with 100% duty 
cycle). Data points are means ± SD. (ex vivo: n = 9, post – mortem study: n = 6) 
 Muscle phantom  
(n = 9) 
Post-mortem study 
(n = 6) 
Surface temperature (°C) 61 ± 3 58 ± 2 
 
As shown in Figure 3-18 and Table 3-12, the thermal effect of US at the skin surface 
was dramatic. Even in the post-mortem sheep, the temperature below the surface 
increased by 5°C. However, temperature increase in live animals would probably be 
less due to the blood circulation. 
3.6 Discussion 
In this Chapter, the effects of formulation type, injection volume and US exposure on 
the spread of IM injections were evaluated. Experiments focused on spread in large 
muscle groups (back and rump) of and post-mortem sheep immediately after 
euthanasia. All formulations contained an oily base and a contrast agent for image 
analysis. The formulations included an oily solution of Lipiodol, a suspension of 
barium sulfate (30%) and SEDDS (composed of 40% Lipiodol, 40% medium chain 
triglycerides and 20% Cremophor). Two injection volumes,1.5 and 4.5 mL, were used 
and injected into a muscular region at a total of 36 sites each separated by at least 
10 cm. After approximately 10 min, US (1.1 MHz, 3 W/cm2, 100% duty cycle) was 
applied to a total of 24 injection sites for either 5 min or 10 min duration.  
As a proof-of-concept, a preliminary study was performed using a porcine muscle 
phantom and fluorescence imaging. This study aimed to evaluate the effect of 
formulation type (oily vs. aqueous) and US exposure on IM spread. To enable image 
analysis, the oily suspension contained Nile blue coated particles and the aqueous 
solution contained solubilized Nile blue. The results of the preliminary study showed 
that exposure to US (1.1 MHz, 6 min, 100% DC, 3 W/cm2) enhanced the spread of both 
formulations. Moving to studies in post-mortem sheep, an imaging protocol for CT 
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scanning was optimized using lamb loin chops. The aim was to determine the optimum 
concentration of contrast agent for imaging. For solutions, sufficient contrast was 
observed for the stock Lipiodol solution containing 48% w/v fatty acid. For 
suspensions, a barium sulfate concentration of 30% w/w was found to provide good 
contrast specificity without increasing the viscosity to a point where injection was 
difficult.  
The spread of an IM injectate within living tissue is a dynamic process that depends on 
how the formulation is expelled from a syringe and the local tissue heterogeneity. To 
evaluate this, an initial characterization of spread was required. This was defined as the 
spread of an oily formulation within the first 10 min of an IM injection in post-mortem 
sheep as evaluated by CT scan. Surprisingly, despite a 3-fold difference in injection 
volume (1.5 mL vs 4.5 mL), no significant difference in the volume of spread was 
observed for any of the three formulations (Section 3.5.4.1). Accordingly, the 
underlying reason(s) for this surprising lack of correlation was explored by dissecting 
the muscle tissue at the injection sites. It was observed that three types of spread 
occurred depending on the tissue structure: (i) within the muscle bundle, (ii) around the 
surface of the muscle bundle, and (iii) along the fat layer(s). Variable spreading profiles 
have also been reported in previous studies (Kaye et al. 1974, Austin et al. 1980a, 
Austin et al. 1980b). For example, spread on the surface of the muscle bundle was 
reported by Bjerregaard et al (2001) and Brown et al (1944) concluded that an oily 
formulation spreads along the fat layer rather than undergoing penetration. 
The above results suggest that the spread of injectable formulations significantly 
depends on the interaction between the formulation and the structure of the muscle 
tissue. Some researchers have suggested it is critical to distinguish between 
intramuscular spread and extramuscular spread. In addition, when injecting a large 
volume, leakage from the intended target can occur due to the injectate exceeding the 
elasticity of the muscle tissue. For example, Gehling (2018) reported extensive 
extramuscular spread on injection of 200 µL of iohexol into the thigh muscle of mice. 
In this case, the injectate was found to spread between the muscle bundle where fat 
layers are usually present. Combined with other research, it suggests that injecting a 
large volume can lead to both intramuscular and extramuscular spread. Because the 
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absorption profiles are quite different (Zuidema et al. 1988), it could explain the erratic 
absorption of some IM injections.  
The influence of US on the spread of IM injections of oily formulations was studied by 
taking post-injection CT scans at the injection site. For IM injections of the oily 
suspension, the spread of the 1.5 mL and 4.5 mL injections was significantly greater 
after exposure to US for 10 min and 5 min respectively. As mentioned previously, even 
with the lower injection volume, some intramuscular spread turns into extramuscular 
spread due to elasticity of the muscle. Once the injectate spreads outside the muscle 
bundle, it normally encounters layers of fat which is less elastic than muscle and 
therefore poses less resistance to spread. Application of US then applies a shear force at 
the injection site to further spread the injectate both intramuscularly and along the fat 
layers. It does this by (i) the high shear rate applied by US thinning the oily suspension 
as the it showed pseudoplastic and its viscosity was lower at higher shear rate (Table 3-
11) and (ii) deceasing the particle size of the suspension through breaking down 
aggregates. Previous studies have shown that smaller particles (< 2-3 μm) pass more 
easily through the fibrous network of muscle (Zuidema et al. 1994). US also causes 
heating and this is discussed below. 
With regard to the significant increase in spread caused by the shorter exposure to US 
for the 4.5 mL injection, it could be due to the greater probability of the formulation 
lying within the focal point of the US beam, since the diameter of the focal point of 
TSG – 7c US transducer is 26 mm. But the maximum length observed of spreading 
patterns was 120 mm in back muscle of post – mortem sheep. Apparently only a part of 
injected formulation was overlaid with US. The effect of a different vehicle used in oily 
suspension (Miglyol) and oily solution (poppy seed oil) is considered as minimal. 
Schultz, et al, injected 400 μL sesame oil and fractionated coconut oil into vastus 
lateralis of rabbits and studied the spread profile (Schultz et al. 1998). No significant 
difference was found in Schultz’s study.  
For SEDDS, the spread of the 1.5 mL injection was significantly increased only by the 
10 min exposure to US as found for the oily suspension. In contrast, the spread of the 
4.5 mL injection was significantly increased by exposure to US for both 5 min and 
10 min duration. US caused about a about 5 °C (Figure 3.21) temperature rise at the 
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depth of the injections. This would have only a small effect on the viscosity of SEDDS 
(Table 3-11). Also, the viscosity of SEDDS dropped only slightly (from 0.05 Pa.s to 
0.03 Pa.s) with increasing shear rate (Table 3-11) suggesting that US would have little 
effect on the viscosity of SEDDS. Therefore it is unlikely that US affected the spread of 
SEDDS by shear thinning of the formulation. Although the heating effect of US on 
viscosity is concluded to be minimal, the heating could lead to some flow due to 
thermal gradients but this was not investigated. Also, it is possible that the increasing 
spread is the result of the ability of US to increase the emulsification of the formulation 
by providing energy for the increasing surface area (Luque de Castro et al. 2007). The 
smaller the oil globules are, the better they can disperse throughout the aqueous 
medium in the surrounding muscle. 
In literature, 3 MHz, 1.5 W/cm2 US for 3.4 min exposure caused 4.5°C increase of 
temperature at a depth of 2.5 cm in muscle of human volunteers (Hayes et al. 2004). In 
this study, 28°C temperature increasement was observed at 4 cm depth in post-mortem 
experiment (Fig 3-18). The much higher raise of temperature in post-mortem model 
could be due to the lack of blood circulation. This is a critical difference between the 
post-mortem model to live model. As the heating may not occur the same effect, the 
thermal gradient in live model is expected smaller than post-mortem model. The effect 
of US on spread of IM injection in live model still needs more investigation. 
No significant effect of US was found following the injection of both 1.5 mL and 
4.5 mL volumes of oily solution for both 5 min and 10 min duration. The literature 
suggests there are two possible mechanisms of spread of oily solutions in muscle: (i) 
the solubilized contrast agent can spread by partitioning from the oily vehicle into the 
surrounding fluid (Hirano et al. 1981b), and (ii) the contrast agent can spread with its 
vehicle if the droplet size is sufficiently small (Weng Larsen et al. 2009). With respect 
to the oily solution, the lack of effect on US on spread may be explained by (i) the low 
partition coefficient of the contrast agent (ethyl esters of iodized fatty acids) that 
compose Lipiodol and (ii) the large droplet size of the oily formulation. With the 
chosen parameters of US, the log P of fatty acids and the droplet size of the formulation 
would not be altered because the heating effect was minimal (from 37°C to 42°C) and 
mechanical actuation due to cavitation was absent (Mujoo et al. 2016). It is possible 
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that with more energy deposition into tissue via US actuation, the heating and shearing 
effects could accelerate the spread of oily solutions. This requires further investigation. 
3.7 Conclusion 
In this chapter, the initial spread of all formulation types and injection volumes were 
measured and shown to be highly variable probably due to the heterogeneity of muscle 
tissue. Exposure to US for 10 min was found to significantly increase the spread of 
1.5 mL and 4.5 mL volumes of oily suspensions and SEDDS. For the suspensions, this 
increase in spread is probably facilitated by the shear force of the applied US which 
reduces the viscosity. For the SEDDS, the viscosity was not changed too much due to 
the shear force from US application, neither the temperature increasement. The 
potential explanation was the US enhanced the emulsification, and the small oil 
globules from the emulsification could disperse throughout the aqueous medium faster. 
The heating effect of US also created a thermal gradient from the surface of skin to 
deep muscle. This thermal gradient may lead to convective flow but requires more 
investigation.  
The use of CT scanning to visualize the spread of IM injections of oily formulations 
was shown to be a suitable strategy. In this study, the spread of IM injected oily 
formulations showed as a bulk from the CT scans. Shape of most bulk of injections 
were thin and long, which is different to sphere from some previous research (Tanaka et 
al. 1974, Hirano et al. 1981a). One major limitation of CT scanning used in this study 
was the resolution was too low. According to Section 1.2, the thickness of perimysium 
in muscle is 30 µm -40 µm. The CT scanning used in this study provided a resolution 
about 0.48 x 0.48 mm/pixel, which suggested this resolution was not sufficient to 
neither visualise the perimysium, nor the spread of IM injected formulation through the 
perimysium. This results showed consistency to another study focused on visualizing 
the pattern and volume of spread of IM injected oily formulation by using magnetic 
resonance imaging (MRI) technology (Kalicharan et al. 2016). Kailicharan’s study also 
suggested resolution was a major limitation to improve the outcome of studies related 
to the spread of IM injections.  
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Aside from the imaging system, there was another limitation in this experimental 
system: the US transducer. The spread of IM injected formulation covered various 
depths and lengths which exceded the area of the US. As showed in Fig 3-18(c), the 
length of some bulk of injection was longer than 30 mm, whereas the diameter of US 
transducer was 26 mm. It is impossible to apply US on the whole bulk of injection 
evenly and simultaneously. Due to the variations in shape and size of the bulk of 
injection, it was hard to determine whether the US transducer covered the whole bulk of 
injection or not. This limitation could increase the error in the results. A real-time 









CHAPTER FOUR  




4.1 GENERAL DISCUSSION 
Two experimental models were tested in this study. In the gel phantom study (Chapter 
2), oily and aqueous solutions were injected into agarose gel and tested with or without 
exposure to US. In the post-mortem sheep study (Chapter 3), an oily solution, 
suspension and a self-emulsifying drug delivery system (SEDDS) were injected into the 
back and rump muscles of lambs. Three durations of exposure to US (0, 5 and 10 min) 
were applied to the injection sites and the volume of spread measured after each 
injection. In Chapter 1, the following research questions were posed:  
• Does US influence the spread of IM injections? 
• Which factors determine the spread of IM injections in model systems and animals?  
Referring to the first research question, significantly increased spread of 1.5 mL and 
4.5 mL IM injections of the oily suspension and SEDDS was found in post-mortem 
sheep after exposure to US (1 MHz, 3 W/cm2, 100% duty cycle) for 10 min. No 
influence of US on the spread of the oily solution was found in either the animal or gel 
phantom study. Also there was no effect of US on the spread of the aqueous solution in 
the gel study.  
Referring to the second research question, the following factors were considered critical 
in determining the spread of IM injections: 
Formulation type 
The spread of the oily suspension and SEDDS was significantly enhanced by exposure 
to US at the injection site but the spread of the oily and aqueous solutions showed no 
response to US. For the oily solution, its hydrophobic nature makes it difficult to spread 
into an aqueous system such as the agarose gel or animal muscle. In contrast, in testing 
the aqueous solution in the gel study, the Nile blue dye diffused rapidly into the 




A rise in temperature resulted from exposure to US in both the gel and post-mortem 
animal studies. For example, the temperature at the injection site in post-mortem sheep 
was found to increase by about 5°C after exposure to US (10 min, 1 MHz and 3W/cm2). 
However, the influence of temperature on the spread of IM injections was not clear 
particularly in the absence of blood flow in post-mortem animals. Further research into 
the influence of temperature on spread in live animals is needed.  
Viscosity and shear force 
In theory, a lower viscosity can enhance the convection of an IM injection. In the post-
mortem animal study, the viscosity of oily suspension was measured by a viscometer at 
various shear rate. The higher shear rate reduced the viscosity of oily suspension 
dramatically. It is speculated that US might cause shear thinning to the oily suspension 
and increased the spread of IM injection oily suspension in the post-mortem sheep.  
Injection volume and duration of US exposure 
There was no significant interaction between injection volume and the duration of US 
crossing all three types of formulation. Noticeably, from Table 3-10, for both SEDDS 
and the oily suspension, a significant increase in spread was observed for the small 
injection volume (1.5 mL) after 10 min exposure to US. For both SEDDS and the oily 
suspension, significant increases in spread were observed for the large injection volume 
(4.5 mL) after only 5 min exposure. These results suggest a large injection volume may 
require a shorter duration of US exposure to enhance spread.  
The hypothesis of this thesis 
The hypothesis of this thesis was that US can enhance the spread of formulations 
administered by IM injection in artificial models or animal muscle. The results show 
that exposure to US (1 MHz 3 W/cm2, 100% duty cycle) for 10 min can enhance the 
spread of an oily suspension and SEDDS. The results also show that temperature, 
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injection volume, viscosity and hydrophilic/hydrophobic properties of the injected 
formulation are important for IM spread.  
Comparing the agarose gel model with post-mortem sheep 
In this thesis, two experimental models were used to study the influence of US on the 
spread of formulations administered by IM injection. Considering the agarose gel 
model, the transparency of agarose gel makes it easy to measure spread using a 
coloured dye. However, gels were unable to withstand injection of large volumes and 
cracked easily. Using premade cavities allowed injection of higher volumes but did not 
properly mimic an IM injection since pressure was not applied. Similarly, although the 
acoustic and thermal properties of agarose gel approximately match those of real 
muscle, agarose gel has neither skin nor a fat layer. In summary, agarose gel is a simple 
and cost-effective means to study IM injections of small volumes but has major 
deficiencies.  
The post-mortem animal model provides the opportunity to study real muscle but 
suffers from the limitations of no blood flow and no muscle contraction. Blood flow 
provides two different effects on the spread of IM injected formulations. The first one is 
a sink condition to allow efficient partitioning of an oily formulation by providing 
sufficient solvent (Anissimov et al. 1999) and can be enhanced by the temperature rise 
induced by US (Robinson et al. 1995) to further increase the spread of an IM injection. 
On the other hand, the blood circulation carries the heat causing by US exposure away 
from the injection area. Then the thermal gradient created by US is supposed to be 
smaller than post-mortem model. It still enhances the convective flow but not as 
strongly as the in post-mortem model. The final impact from blood flow on US 
increased spread of IM injections needs more study. Apart from blood flow, muscle 
contraction and muscle elasticity can add extra shear stress to the injected formulation 
(Havas et al. 1997, Koo et al. 2013). Finally, the selection of an efficient imaging 
technique poses a significant challenge for a post-mortem animal study.  
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4.2 FUTURE DIRECTIONS 
Due to limitations on instrumentation, time and budget, only a few physicochemical 
properties related to the effect of US on the spread of IM injections were studied in this 
thesis. In the future, other physicochemical properties would be worthy of study. For 
example, convective spread could be influenced by the surface tension of an injected 
fluid (Martin 2006) and is worth exploring. Other physicochemical properties such as 
particle size and HLB value are also of interest. 
In terms of US, only the influence of duration of exposure was studied here. The 
frequency and intensity of US are critical for its biological effects and thus the 
influence of different frequencies and intensity of US would be of interest in future 
studies. This is particularly true given that previous research has shown that pulsed high 
intensity and high frequency US (HIFU) enhances penetration of substances into tissue 
and widens the intercellular spaces between epithelial cells (Frenkel 2008). The 
influence of pulsed HIFU on intramuscular spread is also of interest. Acoustic pressure 
was not measured in this study so it was difficult to evaluate the non-thermal effects of 
US on tissue. In future work, a hydrophone could be used to measure the acoustic 
pressure induced by US and thereby illuminate the interaction between US and 
convective spread. Finally, as stated earlier, spread of IM injections in live animals 
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Imaging processing for measuring the area of spread 
Setting scale 
All images captured in gel phantom experiments were processed by software ImageJ 
(Version 1.49, National Institutes of Health, U.S.A). A ruler was included in each 
image to set the scale. For instance, in ImageJ a line equalling 10 mm on the ruler was 
drawn. Then, using the “set scale” function of ImageJ, the “known distance” and the 








Figure 6-1 Using the Set Scale function in ImageJ. (a) The original picture showing the 
phantom gel and the Nile blue dye injectate; a ruler above the gel provides a reference 
for scale; (b) and (c) The user interfaces of ImageJ used to set the scale. 
Selecting the area of interest 
The distribution area of an injection needs to be correctly selected. Before selecting and 
measuring the area of interest, the background noise was reduced by the “subtract 
background” function of ImageJ. The injection area can be selected by “adjusting the 
threshold”, and then using the “binary” function of ImageJ. Finally, the area of interest 
can be set and managed by the “ROI manager” function of ImageJ. In order to ensure a 
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consistent threshold and reduce the variance during image processing, a fixed level of 
threshold was used for all images. The process is shown in the following Figures:  
(a)  (b)  
(c)  
(d)  
Figure 6-2 Processing images using ImageJ. (a) The original picture showing the 
phantom gel and the Nile blue injectate; (b) reducing background noise by subtracting 
the background; (c) adjusting the threshold; and (d) select Binary to convert the picture 
to a white/black image.  
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Area of distribution measurement 
The distribution area of an injectate is selected from Binary images as follows:  
  
 
Figure 6-3. Select the area of interest. 
The distribution area of an injectate can be measured in ImageJ. The “Region of 
interest” (ROI) manager is used to create consistent measurements (yellow block in 
Figure 6-3) in each image. Then the area of the black colour inside the “Region of 
interest” is measured by the “Analysis particles” function in ImageJ.  
Grayscale measurement  
The grayscale of each injection was measured using the following method: 
The original images were set to scale as described in Appendix. Then each image was 
chopped into a consistent size and a line set as region of interest and kept consistent in 
each picture as shown in Figure 6-4 (a).  
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(a) 0 min 
(b) 
   30 min 
   60 min 
(c)  
Figure 6-4 Grayscale measurement. (a) The yellow line indicates the consistent region 
of interest in images taken at various times (0, 30 and 60 mins); (b) selecting the 
function “Multiple plot” in the ROI manager of ImageJ; (c) a typical multiple plot 
which can be exported to Microsoft Excel.  
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The grayscale was then measured by the function “Multiple Plot” in the ROI manager 
of ImageJ as shown in Figure 6-4 (b). Finally, all plots (a typical one shown in Figure 





General Linear Model: Initial spread versus Formulation, 
Injection volume, Block 
Method 
Factor coding (-1, 0, +1) 
Factor Information 
Factor Type Levels Values 
Formulation Fixed 3 SEDDS, Solution, Suspension 
Injection volume Fixed 2 1.5, 4.5 
Block Fixed 2 Back, Rump 
Analysis of Variance 
Source DF Adj SS Adj MS F-Value P-Value 
  Formulation 2 29809510 14904755 0.74 0.488 
  Injection volume 1 21840044 21840044 1.08 0.307 
  Block 1 2150133 2150133 0.11 0.747 
  Formulation*Injection volume 2 5018098 2509049 0.12 0.884 
Error 29 586905530 20238122     
  Lack-of-Fit 5 150644437 30128887 1.66 0.183 
  Pure Error 24 436261093 18177546     
Total 35 645723315       
Model Summary 
S R-sq R-sq(adj) R-sq(pred) 
4498.68 9.11% 0.00% 0.00% 
Coefficients 
Term Coef SE Coef T-Value P-Value VIF 
Constant 7775 750 10.37 0.000   
Formulation           
  SEDDS 1249 1060 1.18 0.248 1.33 
  Solution -893 1060 -0.84 0.407 1.33 
Injection volume           
  1.5 -779 750 -1.04 0.307 1.00 
Block           
  Back 244 750 0.33 0.747 1.00 
Formulation*Injection volume           
  SEDDS 1.5 -204 1060 -0.19 0.849 1.33 
  Solution 1.5 -320 1060 -0.30 0.765 1.33 
Regression Equation 
Initial spread = 7775 + 1249 Formulation_SEDDS - 893 Formulation_Solution 
- 356 Formulation_Suspension - 779 Injection volume_1.5 
+ 779 Injection volume_4.5 + 244 Block_Back - 244 Block_Rump 
- 204 Formulation*Injection volume_SEDDS 1.5 
+ 204 Formulation*Injection volume_SEDDS 4.5 
- 320 Formulation*Injection volume_Solution 1.5 
+ 320 Formulation*Injection volume_Solution 4.5 
+ 524 Formulation*Injection volume_Suspension 1.5 





Comparisons for Initial spread 
Tukey Pairwise Comparisons: Formulation 
Grouping Information Using the Tukey Method and 95% Confidence 
Formulation N Mean Grouping 
SEDDS 12 9024.50 A 
Suspension 12 7419.17 A 
Solution 12 6882.67 A 
Means that do not share a letter are significantly different. 
 
Tukey Pairwise Comparisons: Injection volume 
Grouping Information Using the Tukey Method and 95% Confidence 
Injection 
volume N Mean Grouping 
4.5 18 8554.33 A 
1.5 18 6996.56 A 
Means that do not share a letter are significantly different. 
 
Tukey Pairwise Comparisons: Block 
Grouping Information Using the Tukey Method and 95% Confidence 
Block N Mean Grouping 
Back 18 8019.83 A 
Rump 18 7531.06 A 
Means that do not share a letter are significantly different. 
 
Tukey Pairwise Comparisons: Formulation*Injection volume 
Grouping Information Using the Tukey Method and 95% Confidence 
Formulation*Injection 
volume N Mean Grouping 
SEDDS 4.5 6 10007.2 A 
SEDDS 1.5 6 8041.8 A 
Solution 4.5 6 7981.5 A 
Suspension 4.5 6 7674.3 A 
Suspension 1.5 6 7164.0 A 
Solution 1.5 6 5783.8 A 




Tukey Pairwise Comparisons: Formulation*Block 
Grouping Information Using the Tukey Method and 95% Confidence 
Formulation*Block N Mean Grouping 
SEDDS Back 6 11442.2 A 
Suspension Rump 6 9535.5 A 
Solution Back 6 7314.5 A 
SEDDS Rump 6 6606.8 A 
Solution Rump 6 6450.8 A 
Suspension Back 6 5302.8 A 
Means that do not share a letter are significantly different. 
 
Tukey Pairwise Comparisons: Injection volume*Block 
Grouping Information Using the Tukey Method and 95% Confidence 
Injection 
volume*Block N Mean Grouping 
4.5 Back 9 9396.22 A 
4.5 Rump 9 7712.44 A 
1.5 Rump 9 7349.67 A 
1.5 Back 9 6643.44 A 
Means that do not share a letter are significantly different. 
 
Tukey Pairwise Comparisons: Formulation*Injection volume*Block 
Grouping Information Using the Tukey Method and 95% Confidence 
Formulation*Injection 
volume*Block N Mean Grouping 
SEDDS 4.5 Back 3 12543.7 A 
Suspension 1.5 Rump 3 10752.7 A 
SEDDS 1.5 Back 3 10340.7 A 
Solution 4.5 Back 3 8614.7 A 
Suspension 4.5 Rump 3 8318.3 A 
SEDDS 4.5 Rump 3 7470.7 A 
Solution 4.5 Rump 3 7348.3 A 
Suspension 4.5 Back 3 7030.3 A 
Solution 1.5 Back 3 6014.3 A 
SEDDS 1.5 Rump 3 5743.0 A 
Solution 1.5 Rump 3 5553.3 A 
Suspension 1.5 Back 3 3575.3 A 








Main Effects Plot for Initial spread 
 
 






On exposure to US, the mean spread of the 1.5 mL injections increased by 28% and 
39% with exposure to US for 5 and 10 min respectively. The 4.5 mL injections showed 
a trend of being more sensitive to US showing increases in spread of 44% and 49% 
with exposure to US for 5 and 10 min respectively but this interaction between volume 
and US exposure was not statistically significant (P=0.184).  
 
Figure 8-1 Ratio of  volumes of spread of oily solutions for the 2 CT scans after 
exposure to no US (0) and to US for 5 and 10 min (data are means ± SD, n=2). 
Turning to the oily suspensions, the spread of the control group increased by 27% and 
39% for the 1.5 mL and 4.5 mL injection volumes respectively (Figure 3-15). 
Corresponding increases after 5 and10 min exposure to US were 51% and 66% for the 





































Figure 8-2 Ratio of volumes of spread of oily suspensions for the 2 CT scans after 
exposure to no US (0) and to US for 5 and 10 mins (data are means ± SD, n=2). 
Turning to SEDDS, the spread of the control group increased by 13% and 12% for the 
1.5 mL and 4.5 mL injection volumes respectively (Figure 3-16). Corresponding 
increases after 5 and10 min exposure to US were 33% and 54% for the 1.5 mL 
injections and 49 % and 84% for the 4.5 mL injections. 
 
Figure 8-3 Ratio of volumes of spread of SEDDS for the 2 CT scans after exposure to 
















































































General Linear Model: Spread versus Formulation, Injection 
volume, US duration, Block 
Method 
Factor coding (-1, 0, +1) 
Factor Information 
Factor Type Levels Values 
Formulation Fixed 3 SEDDS, solution, Suspension 
Injection volume Fixed 2 1.5, 4.5 
US duration Fixed 3 0, 5, 10 
Block Fixed 2 Back, Rump 
Analysis of Variance 
Source DF Adj SS Adj MS F-Value P-Value 
  Formulation 2 2161.9 1080.95 21.84 0.000 
  Injection volume 1 1166.2 1166.22 23.57 0.000 
  US duration 2 8357.6 4178.80 84.45 0.000 
  Block 1 150.1 150.06 3.03 0.100 
  Formulation*Injection volume 2 42.3 21.16 0.43 0.659 
  Formulation*US duration 4 1555.8 388.95 7.86 0.001 
  Injection volume*US duration 2 185.4 92.69 1.87 0.184 
  Formulation*Injection volume*US duration 4 552.9 138.23 2.79 0.060 
Error 17 841.2 49.48     
Total 35 15013.4       
Model Summary 
S R-sq R-sq(adj) R-sq(pred) 
7.03442 94.40% 88.46% 74.87% 
Coefficients 
Term Coef SE Coef T-Value P-Value VIF 
Constant 142.31 1.17 121.39 0.000   
Formulation           
  SEDDS -1.80 1.66 -1.08 0.294 1.33 
  solution -8.46 1.66 -5.10 0.000 1.33 
Injection volume           
  1.5 -5.69 1.17 -4.85 0.000 1.00 
US duration           
  0 -20.12 1.66 -12.14 0.000 1.33 
  5 3.39 1.66 2.04 0.057 1.33 
Block           
  Back -2.04 1.17 -1.74 0.100 1.00 
Formulation*Injection volume           
  SEDDS 1.5 -1.48 1.66 -0.89 0.386 1.33 
  solution 1.5 0.37 1.66 0.23 0.824 1.33 
Formulation*US duration           
  SEDDS 0 -8.07 2.34 -3.44 0.003 1.78 
  SEDDS 5 -3.95 2.34 -1.69 0.110 1.78 
  solution 0 7.95 2.34 3.39 0.003 1.78 
  solution 5 -1.11 2.34 -0.47 0.642 1.78 
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Injection volume*US duration           
  1.5 0 2.78 1.66 1.68 0.111 1.33 
  1.5 5 -2.78 1.66 -1.67 0.112 1.33 
Formulation*Injection volume*US duration           
  SEDDS 1.5 0 4.61 2.34 1.97 0.066 1.78 
  SEDDS 1.5 5 2.09 2.34 0.89 0.385 1.78 
  solution 1.5 0 -0.39 2.34 -0.17 0.869 1.78 
  solution 1.5 5 0.32 2.34 0.14 0.894 1.78 
Regression Equation 
Spread = 142.31 - 1.80 Formulation_SEDDS - 8.46 Formulation_solution 
+ 10.26 Formulation_Suspension - 5.69 Injection volume_1.5 
+ 5.69 Injection volume_4.5 - 20.12 US duration_0 + 3.39 US duration_5 
+ 16.74 US duration_10 - 2.04 Block_Back + 2.04 Block_Rump 
- 1.48 Formulation*Injection volume_SEDDS 1.5 
+ 1.48 Formulation*Injection volume_SEDDS 4.5 
+ 0.37 Formulation*Injection volume_solution 1.5 
- 0.37 Formulation*Injection volume_solution 4.5 
+ 1.10 Formulation*Injection volume_Suspension 1.5 
- 1.10 Formulation*Injection volume_Suspension 4.5 
- 8.07 Formulation*US duration_SEDDS 0 - 3.95 Formulation*US duration_SEDDS 5 
+ 12.02 Formulation*US duration_SEDDS 10 + 7.95 Formulation*US duration_solution 0 
- 1.11 Formulation*US duration_solution 5 - 6.84 Formulation*US duration_solution 10 
+ 0.12 Formulation*US duration_Suspension 0 
+ 5.06 Formulation*US duration_Suspension 5 
- 5.19 Formulation*US duration_Suspension 10 + 2.78 Injection volume*US duration_1.5 
0 - 2.78 Injection volume*US duration_1.5 5 - 0.01 Injection volume*US duration_1.5 
10 - 2.78 Injection volume*US duration_4.5 0 + 2.78 Injection volume*US duration_4.5 
5 + 0.01 Injection volume*US duration_4.5 10 
+ 4.61 Formulation*Injection volume*US duration_SEDDS 1.5 0 
+ 2.09 Formulation*Injection volume*US duration_SEDDS 1.5 5 
- 6.70 Formulation*Injection volume*US duration_SEDDS 1.5 10 
- 4.61 Formulation*Injection volume*US duration_SEDDS 4.5 0 
- 2.09 Formulation*Injection volume*US duration_SEDDS 4.5 5 
+ 6.70 Formulation*Injection volume*US duration_SEDDS 4.5 10 
- 0.39 Formulation*Injection volume*US duration_solution 1.5 0 
+ 0.32 Formulation*Injection volume*US duration_solution 1.5 5 
+ 0.07 Formulation*Injection volume*US duration_solution 1.5 10 
+ 0.39 Formulation*Injection volume*US duration_solution 4.5 0 
- 0.32 Formulation*Injection volume*US duration_solution 4.5 5 
- 0.07 Formulation*Injection volume*US duration_solution 4.5 10 
- 4.22 Formulation*Injection volume*US duration_Suspension 1.5 0 
- 2.41 Formulation*Injection volume*US duration_Suspension 1.5 5 
+ 6.63 Formulation*Injection volume*US duration_Suspension 1.5 10 
+ 4.22 Formulation*Injection volume*US duration_Suspension 4.5 0 
+ 2.41 Formulation*Injection volume*US duration_Suspension 4.5 5 
- 6.63 Formulation*Injection volume*US duration_Suspension 4.5 10 
Fits and Diagnostics for Unusual Observations 
Obs Spread Fit Resid Std Resid  
15 160.60 149.21 11.39 2.36 R 
16 141.90 153.29 -11.39 -2.36 R 




Comparisons for Spread 
Tukey Pairwise Comparisons: Formulation 
Grouping Information Using the Tukey Method and 95% Confidence 
Formulation N Mean Grouping 
Suspension 12 152.575 A   
SEDDS 12 140.517   B 
solution 12 133.850   B 
Means that do not share a letter are significantly different. 








95% CI T-Value 
Adjusted 
P-Value 
solution - SEDDS -6.67 3.03 (-14.40, 1.07) -2.20 0.098 
Suspension - SEDDS 12.06 3.03 (4.32, 19.79) 3.98 0.002 
Suspension - solution 18.73 3.03 (10.99, 26.46) 6.18 0.000 
Individual confidence level = 98.00% 
 
Tukey Pairwise Comparisons: Injection volume 
Grouping Information Using the Tukey Method and 95% Confidence 
Injection 
volume N Mean Grouping 
4.5 18 148.006 A   
1.5 18 136.622   B 
Means that do not share a letter are significantly different. 
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95% CI T-Value 
Adjusted 
P-Value 
4.5 - 1.5 11.38 2.47 (6.19, 16.58) 4.60 0.000 
Individual confidence level = 95.00% 
 
Tukey Pairwise Comparisons: US duration 
Grouping Information Using the Tukey Method and 95% Confidence 
US 
duration N Mean Grouping 
10 12 159.050 A     
5 12 145.700   B   
0 12 122.192     C 
Means that do not share a letter are significantly different. 









95% CI T-Value 
Adjusted 
P-Value 
5 - 0 23.51 3.03 (15.77, 31.24) 7.76 0.000 
10 - 0 36.86 3.03 (29.12, 44.59) 12.17 0.000 
10 - 5 13.35 3.03 (5.62, 21.08) 4.41 0.001 




Tukey Pairwise Comparisons: Formulation*Injection volume 
Grouping Information Using the Tukey Method and 95% Confidence 
Formulation*Injection 
volume N Mean Grouping 
Suspension 4.5 6 157.167 A     
Suspension 1.5 6 147.983 A B   
SEDDS 4.5 6 147.683 A B   
solution 4.5 6 139.167   B C 
SEDDS 1.5 6 133.350     C 
solution 1.5 6 128.533     C 
Means that do not share a letter are significantly different. 
Tukey Simultaneous Tests for Differences of Means 







95% CI T-Value 
(SEDDS 4.5) - (SEDDS 1.5) 14.33 4.28 (0.73, 27.94) 3.35 
(solution 1.5) - (SEDDS 1.5) -4.82 4.28 (-18.42, 8.79) -1.12 
(solution 4.5) - (SEDDS 1.5) 5.82 4.28 (-7.79, 19.42) 1.36 
(Suspension 1.5) - (SEDDS 1.5) 14.63 4.28 (1.03, 28.24) 3.42 
(Suspension 4.5) - (SEDDS 1.5) 23.82 4.28 (10.21, 37.42) 5.56 
(solution 1.5) - (SEDDS 4.5) -19.15 4.28 (-32.75, -5.55) -4.47 
(solution 4.5) - (SEDDS 4.5) -8.52 4.28 (-22.12, 5.09) -1.99 
(Suspension 1.5) - (SEDDS 4.5) 0.30 4.28 (-13.30, 13.90) 0.07 
(Suspension 4.5) - (SEDDS 4.5) 9.48 4.28 (-4.12, 23.09) 2.21 
(solution 4.5) - (solution 1.5) 10.63 4.28 (-2.97, 24.24) 2.48 
(Suspension 1.5) - (solution 1.5) 19.45 4.28 (5.85, 33.05) 4.54 
(Suspension 4.5) - (solution 1.5) 28.63 4.28 (15.03, 42.24) 6.68 
(Suspension 1.5) - (solution 4.5) 8.82 4.28 (-4.79, 22.42) 2.06 
(Suspension 4.5) - (solution 4.5) 18.00 4.28 (4.40, 31.60) 4.20 
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(Suspension 4.5) - (Suspension 1.5) 9.18 4.28 (-4.42, 22.79) 2.14 




(SEDDS 4.5) - (SEDDS 1.5) 0.036 
(solution 1.5) - (SEDDS 1.5) 0.865 
(solution 4.5) - (SEDDS 1.5) 0.750 
(Suspension 1.5) - (SEDDS 1.5) 0.031 
(Suspension 4.5) - (SEDDS 1.5) 0.000 
(solution 1.5) - (SEDDS 4.5) 0.003 
(solution 4.5) - (SEDDS 4.5) 0.386 
(Suspension 1.5) - (SEDDS 4.5) 1.000 
(Suspension 4.5) - (SEDDS 4.5) 0.279 
(solution 4.5) - (solution 1.5) 0.181 
(Suspension 1.5) - (solution 1.5) 0.003 
(Suspension 4.5) - (solution 1.5) 0.000 
(Suspension 1.5) - (solution 4.5) 0.351 
(Suspension 4.5) - (solution 4.5) 0.006 
(Suspension 4.5) - (Suspension 1.5) 0.310 
Individual confidence level = 99.48% 
 
Tukey Pairwise Comparisons: Formulation*US duration 
Grouping Information Using the Tukey Method and 95% Confidence 
Formulation*US 
duration N Mean Grouping 
SEDDS 10 4 169.275 A         
Suspension 10 4 164.125 A         
Suspension 5 4 161.025 A B       
solution 10 4 143.750   B C     
SEDDS 5 4 139.950     C D   
solution 5 4 136.125     C D   
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Suspension 0 4 132.575     C D   
solution 0 4 121.675       D E 
SEDDS 0 4 112.325         E 
Means that do not share a letter are significantly different. 
Tukey Simultaneous Tests for Differences of Means 







95% CI T-Value 
Adjusted 
P-Value 
(SEDDS 5) - (SEDDS 0) 27.63 5.25 (9.22, 46.03) 5.26 0.001 
(SEDDS 10) - (SEDDS 0) 56.95 5.25 (38.55, 75.35) 10.85 0.000 
(solution 0) - (SEDDS 0) 9.35 5.25 (-9.05, 27.75) 1.78 0.693 
(solution 5) - (SEDDS 0) 23.80 5.25 (5.40, 42.20) 4.54 0.006 
(solution 10) - (SEDDS 0) 31.42 5.25 (13.02, 49.83) 5.99 0.000 
(Suspension 0) - (SEDDS 0) 20.25 5.25 (1.85, 38.65) 3.86 0.025 
(Suspension 5) - (SEDDS 0) 48.70 5.25 (30.30, 67.10) 9.28 0.000 
(Suspension 10) - (SEDDS 0) 51.80 5.25 (33.40, 70.20) 9.87 0.000 
(SEDDS 10) - (SEDDS 5) 29.32 5.25 (10.92, 47.73) 5.59 0.001 
(solution 0) - (SEDDS 5) -18.27 5.25 (-36.68, 0.13) -3.48 0.052 
(solution 5) - (SEDDS 5) -3.83 5.25 (-22.23, 14.58) -0.73 0.998 
(solution 10) - (SEDDS 5) 3.80 5.25 (-14.60, 22.20) 0.72 0.998 
(Suspension 0) - (SEDDS 5) -7.38 5.25 (-25.78, 11.03) -1.41 0.882 
(Suspension 5) - (SEDDS 5) 21.07 5.25 (2.67, 39.48) 4.02 0.018 
(Suspension 10) - (SEDDS 5) 24.17 5.25 (5.77, 42.58) 4.61 0.005 
(solution 0) - (SEDDS 10) -47.60 5.25 (-66.00, -29.20) -9.07 0.000 
(solution 5) - (SEDDS 10) -33.15 5.25 (-51.55, -14.75) -6.32 0.000 
(solution 10) - (SEDDS 10) -25.53 5.25 (-43.93, -7.12) -4.86 0.003 
(Suspension 0) - (SEDDS 10) -36.70 5.25 (-55.10, -18.30) -6.99 0.000 
(Suspension 5) - (SEDDS 10) -8.25 5.25 (-26.65, 10.15) -1.57 0.807 
(Suspension 10) - (SEDDS 10) -5.15 5.25 (-23.55, 13.25) -0.98 0.983 
(solution 5) - (solution 0) 14.45 5.25 (-3.95, 32.85) 2.75 0.197 
(solution 10) - (solution 0) 22.07 5.25 (3.67, 40.48) 4.21 0.012 
(Suspension 0) - (solution 0) 10.90 5.25 (-7.50, 29.30) 2.08 0.516 
(Suspension 5) - (solution 0) 39.35 5.25 (20.95, 57.75) 7.50 0.000 
(Suspension 10) - (solution 0) 42.45 5.25 (24.05, 60.85) 8.09 0.000 
(solution 10) - (solution 5) 7.62 5.25 (-10.78, 26.03) 1.45 0.862 
(Suspension 0) - (solution 5) -3.55 5.25 (-21.95, 14.85) -0.68 0.999 
(Suspension 5) - (solution 5) 24.90 5.25 (6.50, 43.30) 4.75 0.004 
(Suspension 10) - (solution 5) 28.00 5.25 (9.60, 46.40) 5.34 0.001 
(Suspension 0) - (solution 10) -11.17 5.25 (-29.58, 7.23) -2.13 0.485 
(Suspension 5) - (solution 10) 17.28 5.25 (-1.13, 35.68) 3.29 0.075 
(Suspension 10) - (solution 10) 20.38 5.25 (1.97, 38.78) 3.88 0.024 
(Suspension 5) - (Suspension 0) 28.45 5.25 (10.05, 46.85) 5.42 0.001 
(Suspension 10) - (Suspension 0) 31.55 5.25 (13.15, 49.95) 6.01 0.000 
(Suspension 10) - (Suspension 5) 3.10 5.25 (-15.30, 21.50) 0.59 0.999 




Tukey Pairwise Comparisons: Injection volume*US duration 
Grouping Information Using the Tukey Method and 95% Confidence 
Injection 
volume*US 
duration N Mean Grouping 
4.5 10 6 164.750 A     
4.5 5 6 154.167 A     
1.5 10 6 153.350 A     
1.5 5 6 137.233   B   
4.5 0 6 125.100   B C 
1.5 0 6 119.283     C 
Means that do not share a letter are significantly different. 
Tukey Simultaneous Tests for Differences of Means 
Difference of Injection 






95% CI T-Value 
Adjusted 
P-Value 
(1.5 5) - (1.5 0) 17.95 4.28 (4.35, 31.55) 4.19 0.006 
(1.5 10) - (1.5 0) 34.07 4.28 (20.46, 47.67) 7.95 0.000 
(4.5 0) - (1.5 0) 5.82 4.28 (-7.79, 19.42) 1.36 0.750 
(4.5 5) - (1.5 0) 34.88 4.28 (21.28, 48.49) 8.14 0.000 
(4.5 10) - (1.5 0) 45.47 4.28 (31.86, 59.07) 10.61 0.000 
(1.5 10) - (1.5 5) 16.12 4.28 (2.51, 29.72) 3.76 0.015 
(4.5 0) - (1.5 5) -12.13 4.28 (-25.74, 1.47) -2.83 0.097 
(4.5 5) - (1.5 5) 16.93 4.28 (3.33, 30.54) 3.95 0.010 
(4.5 10) - (1.5 5) 27.52 4.28 (13.91, 41.12) 6.42 0.000 
(4.5 0) - (1.5 10) -28.25 4.28 (-41.85, -14.65) -6.59 0.000 
(4.5 5) - (1.5 10) 0.82 4.28 (-12.79, 14.42) 0.19 1.000 
(4.5 10) - (1.5 10) 11.40 4.28 (-2.20, 25.00) 2.66 0.133 
(4.5 5) - (4.5 0) 29.07 4.28 (15.46, 42.67) 6.78 0.000 
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(4.5 10) - (4.5 0) 39.65 4.28 (26.05, 53.25) 9.25 0.000 
(4.5 10) - (4.5 5) 10.58 4.28 (-3.02, 24.19) 2.47 0.185 
Individual confidence level = 99.48% 
 
Tukey Pairwise Comparisons: Formulation*Injection volume*US duration 
Grouping Information Using the Tukey Method and 95% Confidence 
Formulation*Injection 
volume*US duration N Mean Grouping 
SEDDS 4.5 10 2 183.15 A             
Suspension 4.5 5 2 170.80 A B           
Suspension 1.5 10 2 166.15 A B C         
Suspension 4.5 10 2 162.10 A B C         
SEDDS 1.5 10 2 155.40 A B C D       
Suspension 1.5 5 2 151.25   B C D E     
solution 4.5 10 2 149.00   B C D E     
SEDDS 4.5 5 2 147.80   B C D E F   
solution 4.5 5 2 143.90   B C D E F   
Suspension 4.5 0 2 138.60     C D E F G 
solution 1.5 10 2 138.50     C D E F G 
SEDDS 1.5 5 2 132.10       D E F G 
solution 1.5 5 2 128.35       D E F G 
Suspension 1.5 0 2 126.55       D E F G 
solution 4.5 0 2 124.60         E F G 
solution 1.5 0 2 118.75           F G 
SEDDS 1.5 0 2 112.55             G 
SEDDS 4.5 0 2 112.10             G 




Tukey Simultaneous Tests for Differences of Means 
Difference of Formulation*Injection 






95% CI T-Value 
(SEDDS 1.5 5) - (SEDDS 1.5 0) 19.55 7.42 (-10.31, 49.41) 2.63 
(SEDDS 1.5 10) - (SEDDS 1.5 0) 42.85 7.42 (12.99, 72.71) 5.77 
(SEDDS 4.5 0) - (SEDDS 1.5 0) -0.45 7.42 (-30.31, 29.41) -0.06 
(SEDDS 4.5 5) - (SEDDS 1.5 0) 35.25 7.42 (5.39, 65.11) 4.75 
(SEDDS 4.5 10) - (SEDDS 1.5 0) 70.60 7.42 (40.74, 100.46) 9.51 
(solution 1.5 0) - (SEDDS 1.5 0) 6.20 7.42 (-23.66, 36.06) 0.84 
(solution 1.5 5) - (SEDDS 1.5 0) 15.80 7.42 (-14.06, 45.66) 2.13 
(solution 1.5 10) - (SEDDS 1.5 0) 25.95 7.42 (-3.91, 55.81) 3.50 
(solution 4.5 0) - (SEDDS 1.5 0) 12.05 7.42 (-17.81, 41.91) 1.62 
(solution 4.5 5) - (SEDDS 1.5 0) 31.35 7.42 (1.49, 61.21) 4.22 
(solution 4.5 10) - (SEDDS 1.5 0) 36.45 7.42 (6.59, 66.31) 4.91 
(Suspension 1.5 0) - (SEDDS 1.5 0) 14.00 7.42 (-15.86, 43.86) 1.89 
(Suspension 1.5 5) - (SEDDS 1.5 0) 38.70 7.42 (8.84, 68.56) 5.21 
(Suspension 1.5 10) - (SEDDS 1.5 0) 53.60 7.42 (23.74, 83.46) 7.22 
(Suspension 4.5 0) - (SEDDS 1.5 0) 26.05 7.42 (-3.81, 55.91) 3.51 
(Suspension 4.5 5) - (SEDDS 1.5 0) 58.25 7.42 (28.39, 88.11) 7.85 
(Suspension 4.5 10) - (SEDDS 1.5 0) 49.55 7.42 (19.69, 79.41) 6.68 
(SEDDS 1.5 10) - (SEDDS 1.5 5) 23.30 7.42 (-6.56, 53.16) 3.14 
(SEDDS 4.5 0) - (SEDDS 1.5 5) -20.00 7.42 (-49.86, 9.86) -2.70 
(SEDDS 4.5 5) - (SEDDS 1.5 5) 15.70 7.42 (-14.16, 45.56) 2.12 
(SEDDS 4.5 10) - (SEDDS 1.5 5) 51.05 7.42 (21.19, 80.91) 6.88 
(solution 1.5 0) - (SEDDS 1.5 5) -13.35 7.42 (-43.21, 16.51) -1.80 
(solution 1.5 5) - (SEDDS 1.5 5) -3.75 7.42 (-33.61, 26.11) -0.51 
(solution 1.5 10) - (SEDDS 1.5 5) 6.40 7.42 (-23.46, 36.26) 0.86 
(solution 4.5 0) - (SEDDS 1.5 5) -7.50 7.42 (-37.36, 22.36) -1.01 
(solution 4.5 5) - (SEDDS 1.5 5) 11.80 7.42 (-18.06, 41.66) 1.59 
(solution 4.5 10) - (SEDDS 1.5 5) 16.90 7.42 (-12.96, 46.76) 2.28 
(Suspension 1.5 0) - (SEDDS 1.5 5) -5.55 7.42 (-35.41, 24.31) -0.75 
(Suspension 1.5 5) - (SEDDS 1.5 5) 19.15 7.42 (-10.71, 49.01) 2.58 
(Suspension 1.5 10) - (SEDDS 1.5 5) 34.05 7.42 (4.19, 63.91) 4.59 
(Suspension 4.5 0) - (SEDDS 1.5 5) 6.50 7.42 (-23.36, 36.36) 0.88 
(Suspension 4.5 5) - (SEDDS 1.5 5) 38.70 7.42 (8.84, 68.56) 5.21 
(Suspension 4.5 10) - (SEDDS 1.5 5) 30.00 7.42 (0.14, 59.86) 4.04 
(SEDDS 4.5 0) - (SEDDS 1.5 10) -43.30 7.42 (-73.16, -13.44) -5.83 
(SEDDS 4.5 5) - (SEDDS 1.5 10) -7.60 7.42 (-37.46, 22.26) -1.02 
(SEDDS 4.5 10) - (SEDDS 1.5 10) 27.75 7.42 (-2.11, 57.61) 3.74 
(solution 1.5 0) - (SEDDS 1.5 10) -36.65 7.42 (-66.51, -6.79) -4.94 
(solution 1.5 5) - (SEDDS 1.5 10) -27.05 7.42 (-56.91, 2.81) -3.65 
(solution 1.5 10) - (SEDDS 1.5 10) -16.90 7.42 (-46.76, 12.96) -2.28 
(solution 4.5 0) - (SEDDS 1.5 10) -30.80 7.42 (-60.66, -0.94) -4.15 
(solution 4.5 5) - (SEDDS 1.5 10) -11.50 7.42 (-41.36, 18.36) -1.55 
(solution 4.5 10) - (SEDDS 1.5 10) -6.40 7.42 (-36.26, 23.46) -0.86 
(Suspension 1.5 0) - (SEDDS 1.5 10) -28.85 7.42 (-58.71, 1.01) -3.89 
(Suspension 1.5 5) - (SEDDS 1.5 10) -4.15 7.42 (-34.01, 25.71) -0.56 
(Suspension 1.5 10) - (SEDDS 1.5 10) 10.75 7.42 (-19.11, 40.61) 1.45 
(Suspension 4.5 0) - (SEDDS 1.5 10) -16.80 7.42 (-46.66, 13.06) -2.26 
(Suspension 4.5 5) - (SEDDS 1.5 10) 15.40 7.42 (-14.46, 45.26) 2.08 
(Suspension 4.5 10) - (SEDDS 1.5 10) 6.70 7.42 (-23.16, 36.56) 0.90 
(SEDDS 4.5 5) - (SEDDS 4.5 0) 35.70 7.42 (5.84, 65.56) 4.81 
(SEDDS 4.5 10) - (SEDDS 4.5 0) 71.05 7.42 (41.19, 100.91) 9.57 
(solution 1.5 0) - (SEDDS 4.5 0) 6.65 7.42 (-23.21, 36.51) 0.90 
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(solution 1.5 5) - (SEDDS 4.5 0) 16.25 7.42 (-13.61, 46.11) 2.19 
(solution 1.5 10) - (SEDDS 4.5 0) 26.40 7.42 (-3.46, 56.26) 3.56 
(solution 4.5 0) - (SEDDS 4.5 0) 12.50 7.42 (-17.36, 42.36) 1.68 
(solution 4.5 5) - (SEDDS 4.5 0) 31.80 7.42 (1.94, 61.66) 4.29 
(solution 4.5 10) - (SEDDS 4.5 0) 36.90 7.42 (7.04, 66.76) 4.97 
(Suspension 1.5 0) - (SEDDS 4.5 0) 14.45 7.42 (-15.41, 44.31) 1.95 
(Suspension 1.5 5) - (SEDDS 4.5 0) 39.15 7.42 (9.29, 69.01) 5.28 
(Suspension 1.5 10) - (SEDDS 4.5 0) 54.05 7.42 (24.19, 83.91) 7.28 
(Suspension 4.5 0) - (SEDDS 4.5 0) 26.50 7.42 (-3.36, 56.36) 3.57 
(Suspension 4.5 5) - (SEDDS 4.5 0) 58.70 7.42 (28.84, 88.56) 7.91 
(Suspension 4.5 10) - (SEDDS 4.5 0) 50.00 7.42 (20.14, 79.86) 6.74 
(SEDDS 4.5 10) - (SEDDS 4.5 5) 35.35 7.42 (5.49, 65.21) 4.76 
(solution 1.5 0) - (SEDDS 4.5 5) -29.05 7.42 (-58.91, 0.81) -3.91 
(solution 1.5 5) - (SEDDS 4.5 5) -19.45 7.42 (-49.31, 10.41) -2.62 
(solution 1.5 10) - (SEDDS 4.5 5) -9.30 7.42 (-39.16, 20.56) -1.25 
(solution 4.5 0) - (SEDDS 4.5 5) -23.20 7.42 (-53.06, 6.66) -3.13 
(solution 4.5 5) - (SEDDS 4.5 5) -3.90 7.42 (-33.76, 25.96) -0.53 
(solution 4.5 10) - (SEDDS 4.5 5) 1.20 7.42 (-28.66, 31.06) 0.16 
(Suspension 1.5 0) - (SEDDS 4.5 5) -21.25 7.42 (-51.11, 8.61) -2.86 
(Suspension 1.5 5) - (SEDDS 4.5 5) 3.45 7.42 (-26.41, 33.31) 0.46 
(Suspension 1.5 10) - (SEDDS 4.5 5) 18.35 7.42 (-11.51, 48.21) 2.47 
(Suspension 4.5 0) - (SEDDS 4.5 5) -9.20 7.42 (-39.06, 20.66) -1.24 
(Suspension 4.5 5) - (SEDDS 4.5 5) 23.00 7.42 (-6.86, 52.86) 3.10 
(Suspension 4.5 10) - (SEDDS 4.5 5) 14.30 7.42 (-15.56, 44.16) 1.93 
(solution 1.5 0) - (SEDDS 4.5 10) -64.40 7.42 (-94.26, -34.54) -8.68 
(solution 1.5 5) - (SEDDS 4.5 10) -54.80 7.42 (-84.66, -24.94) -7.38 
(solution 1.5 10) - (SEDDS 4.5 10) -44.65 7.42 (-74.51, -14.79) -6.02 
(solution 4.5 0) - (SEDDS 4.5 10) -58.55 7.42 (-88.41, -28.69) -7.89 
(solution 4.5 5) - (SEDDS 4.5 10) -39.25 7.42 (-69.11, -9.39) -5.29 
(solution 4.5 10) - (SEDDS 4.5 10) -34.15 7.42 (-64.01, -4.29) -4.60 
(Suspension 1.5 0) - (SEDDS 4.5 10) -56.60 7.42 (-86.46, -26.74) -7.63 
(Suspension 1.5 5) - (SEDDS 4.5 10) -31.90 7.42 (-61.76, -2.04) -4.30 
(Suspension 1.5 10) - (SEDDS 4.5 10) -17.00 7.42 (-46.86, 12.86) -2.29 
(Suspension 4.5 0) - (SEDDS 4.5 10) -44.55 7.42 (-74.41, -14.69) -6.00 
(Suspension 4.5 5) - (SEDDS 4.5 10) -12.35 7.42 (-42.21, 17.51) -1.66 
(Suspension 4.5 10) - (SEDDS 4.5 10) -21.05 7.42 (-50.91, 8.81) -2.84 
(solution 1.5 5) - (solution 1.5 0) 9.60 7.42 (-20.26, 39.46) 1.29 
(solution 1.5 10) - (solution 1.5 0) 19.75 7.42 (-10.11, 49.61) 2.66 
(solution 4.5 0) - (solution 1.5 0) 5.85 7.42 (-24.01, 35.71) 0.79 
(solution 4.5 5) - (solution 1.5 0) 25.15 7.42 (-4.71, 55.01) 3.39 
(solution 4.5 10) - (solution 1.5 0) 30.25 7.42 (0.39, 60.11) 4.08 
(Suspension 1.5 0) - (solution 1.5 0) 7.80 7.42 (-22.06, 37.66) 1.05 
(Suspension 1.5 5) - (solution 1.5 0) 32.50 7.42 (2.64, 62.36) 4.38 
(Suspension 1.5 10) - (solution 1.5 0) 47.40 7.42 (17.54, 77.26) 6.39 
(Suspension 4.5 0) - (solution 1.5 0) 19.85 7.42 (-10.01, 49.71) 2.67 
(Suspension 4.5 5) - (solution 1.5 0) 52.05 7.42 (22.19, 81.91) 7.01 
(Suspension 4.5 10) - (solution 1.5 0) 43.35 7.42 (13.49, 73.21) 5.84 
(solution 1.5 10) - (solution 1.5 5) 10.15 7.42 (-19.71, 40.01) 1.37 
(solution 4.5 0) - (solution 1.5 5) -3.75 7.42 (-33.61, 26.11) -0.51 
(solution 4.5 5) - (solution 1.5 5) 15.55 7.42 (-14.31, 45.41) 2.10 
(solution 4.5 10) - (solution 1.5 5) 20.65 7.42 (-9.21, 50.51) 2.78 
(Suspension 1.5 0) - (solution 1.5 5) -1.80 7.42 (-31.66, 28.06) -0.24 
(Suspension 1.5 5) - (solution 1.5 5) 22.90 7.42 (-6.96, 52.76) 3.09 
(Suspension 1.5 10) - (solution 1.5 5) 37.80 7.42 (7.94, 67.66) 5.09 
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(Suspension 4.5 0) - (solution 1.5 5) 10.25 7.42 (-19.61, 40.11) 1.38 
(Suspension 4.5 5) - (solution 1.5 5) 42.45 7.42 (12.59, 72.31) 5.72 
(Suspension 4.5 10) - (solution 1.5 5) 33.75 7.42 (3.89, 63.61) 4.55 
(solution 4.5 0) - (solution 1.5 10) -13.90 7.42 (-43.76, 15.96) -1.87 
(solution 4.5 5) - (solution 1.5 10) 5.40 7.42 (-24.46, 35.26) 0.73 
(solution 4.5 10) - (solution 1.5 10) 10.50 7.42 (-19.36, 40.36) 1.41 
(Suspension 1.5 0) - (solution 1.5 10) -11.95 7.42 (-41.81, 17.91) -1.61 
(Suspension 1.5 5) - (solution 1.5 10) 12.75 7.42 (-17.11, 42.61) 1.72 
(Suspension 1.5 10) - (solution 1.5 10) 27.65 7.42 (-2.21, 57.51) 3.73 
(Suspension 4.5 0) - (solution 1.5 10) 0.10 7.42 (-29.76, 29.96) 0.01 
(Suspension 4.5 5) - (solution 1.5 10) 32.30 7.42 (2.44, 62.16) 4.35 
(Suspension 4.5 10) - (solution 1.5 10) 23.60 7.42 (-6.26, 53.46) 3.18 
(solution 4.5 5) - (solution 4.5 0) 19.30 7.42 (-10.56, 49.16) 2.60 
(solution 4.5 10) - (solution 4.5 0) 24.40 7.42 (-5.46, 54.26) 3.29 
(Suspension 1.5 0) - (solution 4.5 0) 1.95 7.42 (-27.91, 31.81) 0.26 
(Suspension 1.5 5) - (solution 4.5 0) 26.65 7.42 (-3.21, 56.51) 3.59 
(Suspension 1.5 10) - (solution 4.5 0) 41.55 7.42 (11.69, 71.41) 5.60 
(Suspension 4.5 0) - (solution 4.5 0) 14.00 7.42 (-15.86, 43.86) 1.89 
(Suspension 4.5 5) - (solution 4.5 0) 46.20 7.42 (16.34, 76.06) 6.23 
(Suspension 4.5 10) - (solution 4.5 0) 37.50 7.42 (7.64, 67.36) 5.05 
(solution 4.5 10) - (solution 4.5 5) 5.10 7.42 (-24.76, 34.96) 0.69 
(Suspension 1.5 0) - (solution 4.5 5) -17.35 7.42 (-47.21, 12.51) -2.34 
(Suspension 1.5 5) - (solution 4.5 5) 7.35 7.42 (-22.51, 37.21) 0.99 
(Suspension 1.5 10) - (solution 4.5 5) 22.25 7.42 (-7.61, 52.11) 3.00 
(Suspension 4.5 0) - (solution 4.5 5) -5.30 7.42 (-35.16, 24.56) -0.71 
(Suspension 4.5 5) - (solution 4.5 5) 26.90 7.42 (-2.96, 56.76) 3.62 
(Suspension 4.5 10) - (solution 4.5 5) 18.20 7.42 (-11.66, 48.06) 2.45 
(Suspension 1.5 0) - (solution 4.5 10) -22.45 7.42 (-52.31, 7.41) -3.03 
(Suspension 1.5 5) - (solution 4.5 10) 2.25 7.42 (-27.61, 32.11) 0.30 
(Suspension 1.5 10) - (solution 4.5 10) 17.15 7.42 (-12.71, 47.01) 2.31 
(Suspension 4.5 0) - (solution 4.5 10) -10.40 7.42 (-40.26, 19.46) -1.40 
(Suspension 4.5 5) - (solution 4.5 10) 21.80 7.42 (-8.06, 51.66) 2.94 
(Suspension 4.5 10) - (solution 4.5 10) 13.10 7.42 (-16.76, 42.96) 1.77 
(Suspension 1.5 5) - (Suspension 1.5 0) 24.70 7.42 (-5.16, 54.56) 3.33 
(Suspension 1.5 10) - (Suspension 1.5 0) 39.60 7.42 (9.74, 69.46) 5.34 
(Suspension 4.5 0) - (Suspension 1.5 0) 12.05 7.42 (-17.81, 41.91) 1.62 
(Suspension 4.5 5) - (Suspension 1.5 0) 44.25 7.42 (14.39, 74.11) 5.96 
(Suspension 4.5 10) - (Suspension 1.5 0) 35.55 7.42 (5.69, 65.41) 4.79 
(Suspension 1.5 10) - (Suspension 1.5 5) 14.90 7.42 (-14.96, 44.76) 2.01 
(Suspension 4.5 0) - (Suspension 1.5 5) -12.65 7.42 (-42.51, 17.21) -1.70 
(Suspension 4.5 5) - (Suspension 1.5 5) 19.55 7.42 (-10.31, 49.41) 2.63 
(Suspension 4.5 10) - (Suspension 1.5 5) 10.85 7.42 (-19.01, 40.71) 1.46 
(Suspension 4.5 0) - (Suspension 1.5 10) -27.55 7.42 (-57.41, 2.31) -3.71 
(Suspension 4.5 5) - (Suspension 1.5 10) 4.65 7.42 (-25.21, 34.51) 0.63 
(Suspension 4.5 10) - (Suspension 1.5 10) -4.05 7.42 (-33.91, 25.81) -0.55 
(Suspension 4.5 5) - (Suspension 4.5 0) 32.20 7.42 (2.34, 62.06) 4.34 
(Suspension 4.5 10) - (Suspension 4.5 0) 23.50 7.42 (-6.36, 53.36) 3.17 
(Suspension 4.5 10) - (Suspension 4.5 5) -8.70 7.42 (-38.56, 21.16) -1.17 
Difference of Formulation*Injection 
volume*US duration Levels 
Adjusted 
P-Value 
(SEDDS 1.5 5) - (SEDDS 1.5 0) 0.477 
(SEDDS 1.5 10) - (SEDDS 1.5 0) 0.002 
(SEDDS 4.5 0) - (SEDDS 1.5 0) 1.000 
(SEDDS 4.5 5) - (SEDDS 1.5 0) 0.012 
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(SEDDS 4.5 10) - (SEDDS 1.5 0) 0.000 
(solution 1.5 0) - (SEDDS 1.5 0) 1.000 
(solution 1.5 5) - (SEDDS 1.5 0) 0.772 
(solution 1.5 10) - (SEDDS 1.5 0) 0.130 
(solution 4.5 0) - (SEDDS 1.5 0) 0.960 
(solution 4.5 5) - (SEDDS 1.5 0) 0.034 
(solution 4.5 10) - (SEDDS 1.5 0) 0.009 
(Suspension 1.5 0) - (SEDDS 1.5 0) 0.884 
(Suspension 1.5 5) - (SEDDS 1.5 0) 0.005 
(Suspension 1.5 10) - (SEDDS 1.5 0) 0.000 
(Suspension 4.5 0) - (SEDDS 1.5 0) 0.127 
(Suspension 4.5 5) - (SEDDS 1.5 0) 0.000 
(Suspension 4.5 10) - (SEDDS 1.5 0) 0.000 
(SEDDS 1.5 10) - (SEDDS 1.5 5) 0.236 
(SEDDS 4.5 0) - (SEDDS 1.5 5) 0.443 
(SEDDS 4.5 5) - (SEDDS 1.5 5) 0.779 
(SEDDS 4.5 10) - (SEDDS 1.5 5) 0.000 
(solution 1.5 0) - (SEDDS 1.5 5) 0.915 
(solution 1.5 5) - (SEDDS 1.5 5) 1.000 
(solution 1.5 10) - (SEDDS 1.5 5) 1.000 
(solution 4.5 0) - (SEDDS 1.5 5) 1.000 
(solution 4.5 5) - (SEDDS 1.5 5) 0.966 
(solution 4.5 10) - (SEDDS 1.5 5) 0.688 
(Suspension 1.5 0) - (SEDDS 1.5 5) 1.000 
(Suspension 1.5 5) - (SEDDS 1.5 5) 0.508 
(Suspension 1.5 10) - (SEDDS 1.5 5) 0.017 
(Suspension 4.5 0) - (SEDDS 1.5 5) 1.000 
(Suspension 4.5 5) - (SEDDS 1.5 5) 0.005 
(Suspension 4.5 10) - (SEDDS 1.5 5) 0.048 
(SEDDS 4.5 0) - (SEDDS 1.5 10) 0.001 
(SEDDS 4.5 5) - (SEDDS 1.5 10) 1.000 
(SEDDS 4.5 10) - (SEDDS 1.5 10) 0.085 
(solution 1.5 0) - (SEDDS 1.5 10) 0.008 
(solution 1.5 5) - (SEDDS 1.5 10) 0.100 
(solution 1.5 10) - (SEDDS 1.5 10) 0.688 
(solution 4.5 0) - (SEDDS 1.5 10) 0.039 
(solution 4.5 5) - (SEDDS 1.5 10) 0.973 
(solution 4.5 10) - (SEDDS 1.5 10) 1.000 
(Suspension 1.5 0) - (SEDDS 1.5 10) 0.064 
(Suspension 1.5 5) - (SEDDS 1.5 10) 1.000 
(Suspension 1.5 10) - (SEDDS 1.5 10) 0.985 
(Suspension 4.5 0) - (SEDDS 1.5 10) 0.696 
(Suspension 4.5 5) - (SEDDS 1.5 10) 0.800 
(Suspension 4.5 10) - (SEDDS 1.5 10) 1.000 
(SEDDS 4.5 5) - (SEDDS 4.5 0) 0.011 
(SEDDS 4.5 10) - (SEDDS 4.5 0) 0.000 
(solution 1.5 0) - (SEDDS 4.5 0) 1.000 
(solution 1.5 5) - (SEDDS 4.5 0) 0.739 
(solution 1.5 10) - (SEDDS 4.5 0) 0.117 
(solution 4.5 0) - (SEDDS 4.5 0) 0.947 
(solution 4.5 5) - (SEDDS 4.5 0) 0.030 
(solution 4.5 10) - (SEDDS 4.5 0) 0.008 
(Suspension 1.5 0) - (SEDDS 4.5 0) 0.860 
(Suspension 1.5 5) - (SEDDS 4.5 0) 0.004 
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(Suspension 1.5 10) - (SEDDS 4.5 0) 0.000 
(Suspension 4.5 0) - (SEDDS 4.5 0) 0.115 
(Suspension 4.5 5) - (SEDDS 4.5 0) 0.000 
(Suspension 4.5 10) - (SEDDS 4.5 0) 0.000 
(SEDDS 4.5 10) - (SEDDS 4.5 5) 0.012 
(solution 1.5 0) - (SEDDS 4.5 5) 0.061 
(solution 1.5 5) - (SEDDS 4.5 5) 0.485 
(solution 1.5 10) - (SEDDS 4.5 5) 0.996 
(solution 4.5 0) - (SEDDS 4.5 5) 0.241 
(solution 4.5 5) - (SEDDS 4.5 5) 1.000 
(solution 4.5 10) - (SEDDS 4.5 5) 1.000 
(Suspension 1.5 0) - (SEDDS 4.5 5) 0.355 
(Suspension 1.5 5) - (SEDDS 4.5 5) 1.000 
(Suspension 1.5 10) - (SEDDS 4.5 5) 0.572 
(Suspension 4.5 0) - (SEDDS 4.5 5) 0.997 
(Suspension 4.5 5) - (SEDDS 4.5 5) 0.251 
(Suspension 4.5 10) - (SEDDS 4.5 5) 0.868 
(solution 1.5 0) - (SEDDS 4.5 10) 0.000 
(solution 1.5 5) - (SEDDS 4.5 10) 0.000 
(solution 1.5 10) - (SEDDS 4.5 10) 0.001 
(solution 4.5 0) - (SEDDS 4.5 10) 0.000 
(solution 4.5 5) - (SEDDS 4.5 10) 0.004 
(solution 4.5 10) - (SEDDS 4.5 10) 0.016 
(Suspension 1.5 0) - (SEDDS 4.5 10) 0.000 
(Suspension 1.5 5) - (SEDDS 4.5 10) 0.029 
(Suspension 1.5 10) - (SEDDS 4.5 10) 0.681 
(Suspension 4.5 0) - (SEDDS 4.5 10) 0.001 
(Suspension 4.5 5) - (SEDDS 4.5 10) 0.951 
(Suspension 4.5 10) - (SEDDS 4.5 10) 0.368 
(solution 1.5 5) - (solution 1.5 0) 0.995 
(solution 1.5 10) - (solution 1.5 0) 0.462 
(solution 4.5 0) - (solution 1.5 0) 1.000 
(solution 4.5 5) - (solution 1.5 0) 0.157 
(solution 4.5 10) - (solution 1.5 0) 0.045 
(Suspension 1.5 0) - (solution 1.5 0) 0.999 
(Suspension 1.5 5) - (solution 1.5 0) 0.025 
(Suspension 1.5 10) - (solution 1.5 0) 0.001 
(Suspension 4.5 0) - (solution 1.5 0) 0.454 
(Suspension 4.5 5) - (solution 1.5 0) 0.000 
(Suspension 4.5 10) - (solution 1.5 0) 0.001 
(solution 1.5 10) - (solution 1.5 5) 0.991 
(solution 4.5 0) - (solution 1.5 5) 1.000 
(solution 4.5 5) - (solution 1.5 5) 0.789 
(solution 4.5 10) - (solution 1.5 5) 0.396 
(Suspension 1.5 0) - (solution 1.5 5) 1.000 
(Suspension 1.5 5) - (solution 1.5 5) 0.256 
(Suspension 1.5 10) - (solution 1.5 5) 0.006 
(Suspension 4.5 0) - (solution 1.5 5) 0.990 
(Suspension 4.5 5) - (solution 1.5 5) 0.002 
(Suspension 4.5 10) - (solution 1.5 5) 0.018 
(solution 4.5 0) - (solution 1.5 10) 0.889 
(solution 4.5 5) - (solution 1.5 10) 1.000 
(solution 4.5 10) - (solution 1.5 10) 0.988 
(Suspension 1.5 0) - (solution 1.5 10) 0.962 
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(Suspension 1.5 5) - (solution 1.5 10) 0.938 
(Suspension 1.5 10) - (solution 1.5 10) 0.087 
(Suspension 4.5 0) - (solution 1.5 10) 1.000 
(Suspension 4.5 5) - (solution 1.5 10) 0.027 
(Suspension 4.5 10) - (solution 1.5 10) 0.221 
(solution 4.5 5) - (solution 4.5 0) 0.496 
(solution 4.5 10) - (solution 4.5 0) 0.186 
(Suspension 1.5 0) - (solution 4.5 0) 1.000 
(Suspension 1.5 5) - (solution 4.5 0) 0.111 
(Suspension 1.5 10) - (solution 4.5 0) 0.002 
(Suspension 4.5 0) - (solution 4.5 0) 0.884 
(Suspension 4.5 5) - (solution 4.5 0) 0.001 
(Suspension 4.5 10) - (solution 4.5 0) 0.007 
(solution 4.5 10) - (solution 4.5 5) 1.000 
(Suspension 1.5 0) - (solution 4.5 5) 0.653 
(Suspension 1.5 5) - (solution 4.5 5) 1.000 
(Suspension 1.5 10) - (solution 4.5 5) 0.292 
(Suspension 4.5 0) - (solution 4.5 5) 1.000 
(Suspension 4.5 5) - (solution 4.5 5) 0.104 
(Suspension 4.5 10) - (solution 4.5 5) 0.584 
(Suspension 1.5 0) - (solution 4.5 10) 0.281 
(Suspension 1.5 5) - (solution 4.5 10) 1.000 
(Suspension 1.5 10) - (solution 4.5 10) 0.669 
(Suspension 4.5 0) - (solution 4.5 10) 0.989 
(Suspension 4.5 5) - (solution 4.5 10) 0.319 
(Suspension 4.5 10) - (solution 4.5 10) 0.925 
(Suspension 1.5 5) - (Suspension 1.5 0) 0.174 
(Suspension 1.5 10) - (Suspension 1.5 0) 0.004 
(Suspension 4.5 0) - (Suspension 1.5 0) 0.960 
(Suspension 4.5 5) - (Suspension 1.5 0) 0.001 
(Suspension 4.5 10) - (Suspension 1.5 0) 0.011 
(Suspension 1.5 10) - (Suspension 1.5 5) 0.832 
(Suspension 4.5 0) - (Suspension 1.5 5) 0.942 
(Suspension 4.5 5) - (Suspension 1.5 5) 0.477 
(Suspension 4.5 10) - (Suspension 1.5 5) 0.983 
(Suspension 4.5 0) - (Suspension 1.5 10) 0.089 
(Suspension 4.5 5) - (Suspension 1.5 10) 1.000 
(Suspension 4.5 10) - (Suspension 1.5 10) 1.000 
(Suspension 4.5 5) - (Suspension 4.5 0) 0.027 
(Suspension 4.5 10) - (Suspension 4.5 0) 0.226 
(Suspension 4.5 10) - (Suspension 4.5 5) 0.998 
Individual confidence level = 99.92% 
* NOTE * Cannot draw the interval plot for the Tukey procedure. Interval plots for 
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